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ABSTRACT
This article reviews the mechanistic basis of the tissue residue approach for toxicity assessment (TRA). The tissue residue
approach implies that whole-body or organ concentrations (residues) are a better dosemetric for describing toxicity to aquatic
organisms than is the aqueous concentration typically used in the external medium. Although the benefit of internal
concentrations as dose metrics in ecotoxicology has long been recognized, the application of the tissue residue approach
remains limited. The main factor responsible for this is the difficulty of measuring internal concentrations. We propose that
environmental toxicology can advance if mechanistic considerations are implemented and toxicokinetics and toxicodynamics
are explicitly addressed. The variability in ecotoxicological outcomes and species sensitivity is due in part to differences in
toxicokinetics, which consist of several processes, including absorption, distribution, metabolism, and excretion (ADME), that
influence internal concentrations. Using internal concentrations or tissue residues as the dose metric substantially reduces the
variability in toxicity metrics among species and individuals exposed under varying conditions. Total internal concentrations are
useful as dosemetrics only if they represent a surrogate of the biologically effective dose, the concentration or dose at the target
site. If there is no direct proportionality, we advise the implementation of comprehensive toxicokinetic models that include
deriving the target dose. Depending on the mechanism of toxicity, the concentration at the target site may or may not be a
sufficient descriptor of toxicity. The steady-state concentrationof abaseline toxicant associatedwith thebiologicalmembrane is
a good descriptor of the toxicodynamics of baseline toxicity. When assessing specific-acting and reactive mechanisms,
additional parameters (e.g., reaction rate with the target site and regeneration of the target site) are needed for
characterization. For specifically acting compounds, intrinsic potency depends on 1) affinity for, and 2) type of interaction
with, a receptor or a target enzyme. These 2 parameters determine the selectivity for the toxic mechanism and the sensitivity,
respectively. Implementationofmechanistic information in toxicokinetic–toxicodynamic (TK–TD)modelsmayhelp explain time-
delayed effects, toxicity after pulsed or fluctuating exposure, carryover toxicity after sequential pulses, andmixture toxicity. We
believe that this mechanistic understanding of tissue residue toxicity will lead to improved environmental risk assessment.
Integr Environ Assess Manag 2011;7:28–49.  2010 SETAC
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INTRODUCTION
Measured tissue residues or internal concentrations of
organic chemicals in biological organisms are a better
descriptor of toxicity and show less variability, as compared
with external exposure-based effect concentrations, with
respect to species sensitivity and time dependence of toxicity
Integrated Environmental Assessment and Management — Volume 7, Number 1—pp. 28–49
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EDITOR’S NOTE
This paper represents 1 of 6 review articles generated from a SETAC Pellston Workshop entitled ‘‘The Tissue Residue
Approach for Toxicity Assessment (TRA)’’ (June 2007, Leavenworth, Washington, USA). The main workshop objectives were
to review and evaluate the science behind using tissue residues as the dose metric for characterizing toxic responses and to
explore the utility of the TRA for mixtures, guidelines or criteria, and ecological risk assessment.
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(McCarty et al. 2011). The generally lower variability
observed for tissue residue toxicity metrics is primarily a
result of their independence of the variability inherent in
bioavailability, external toxicokinetics, and bioaccumulation
factors. Nevertheless, tissue residues remain only a surrogate
for the dose at the target site, termed the biologically effective
dose (BED) (Paustenbach 2000). The underlying mechanistic
processes determines whether tissue residues are sufficient
surrogates of the BED, or if more sophisticated time-resolved
toxicokinetic–toxicodynamic models need to be used (Mea-
dor et al. 2008; Ashauer and Brown 2008).
In the present work, we review the mechanistic basis of the
tissue residue approach for toxicity assessment (TRA) for
organic chemicals and explore the benefits and limitations of
this approach. As Hendriks et al. (2005) stated, ‘‘The lethal
body burden concept appears promising but controversial.’’
These investigators also claimed that ‘‘The concept has
mainly been used for narcotics, and application to other
modes of action is limited.’’ Nevertheless, the TRA is being
applied in practice, especially in the context of resolved and
unresolved mixtures in the environment (Dyer et al. 2011). In
addition, environmental quality criteria for organic chemicals
are being derived from internal effect concentrations (Traas et
al. 2004; Meador 2006).
In this review, we explore why the application of TRA in
regulatory risk assessment remains absent or very limited
despite many decades of advocacy and recent scientific
advances (McCarty and Mackay 1993; Sijm and Hermens
2000; Escher and Hermens 2004; Meador et al. 2008, and
references cited therein). We demonstrate that the TRA
remains intrinsically limited if it is targeted at determining
steady-state, whole-organism concentrations but may further
advance if it is focused on target site concentrations and if
toxicokinetic and toxicodynamic characteristics are inte-
grated. A number of promising approaches have been pro-
posed in recent years; they have in common that they clearly
differentiate between the toxicokinetics and toxicodynamics.
Toxicokinetics encompass many processes, including
uptake, distribution to target and nontarget sites, metabolism,
and excretion (Figure 1). Owing to toxicokinetic processes, a
toxicant reaches its target sites, where the type and degree of
interaction determine its toxic effect and potency. The
process of toxicant–target interaction and the subsequent
effects at the suborganism or organism level, including
physiological processes, are called toxicodynamics. The
degree and rate of reversibility of the interaction at the
toxicant–target site, as well as any compensating mechanisms
that result in thresholds or recovery, are determined by the
toxic mechanism and the intrinsic potency of a given
compound. It is important to note that both organism-specific
and species-specific characteristics affect the target, including
age, lipid content, and fitness, in addition to numerous species
differences.
The literature provides no consistent definition of the
terms ‘‘toxic mechanism of action’’ and ‘‘mode of action.’’
For the present work, we use the following definitions: A
toxic mechanism of action (MeOA) refers to either the
crucial biochemical processes, or xenobiotic–biological inter-
actions, or both, underlying a given mode of action (Rand
et al. 1995). A mode of action (MoOA) is a common set of
physiological and behavioral signs that characterize a type of
adverse biological response. The literature often makes no
clear distinction between MoOA and MeOA. Inclusion of
mechanistic information in the tissue residue concept must
consider the definition of toxic mechanisms. The conceptual
idea here is that at a defined occupation of, or reaction with,
the target site by a toxicant produces a defined effect. In
general, a target site can refer to receptors such as enzyme
active sites or a domain (e.g., a membrane lipid bilayer).
The strength of the interaction between a toxicant and the
target is an indication of the intrinsic potency of the
compound. It is possible to classify toxic mechanisms based
on the type and degree of interaction with the target molecule
or site (Escher and Hermens 2002). We will review how
chemicals can be classified into different toxic mechanisms on
the basis of these interactions with the target site. This
information can then be related to the chemical structure-
oriented classification (Verhaar et al. 1992, 1996; Bradbury
1994) to target site-based classification schemes (Nendza
et al. 1995; Escher and Hermens 2002; Nendza and
Wenzel 2006) and to those derived from physiological
observations and modes of action (McKim et al. 1987a;
Bradbury 1994).
Measured (whole-body) tissue residues are typically
referred to as either critical body residue (CBR) or lethal
body burden (LBB). Lethal body burden can be expressed in
concentration units but is often also expressed as amount per
organism. The terms critical (as in CBR) and effective internal
concentrations refer generally to nonlethal or sublethal
effects. CBR is also used as a general overarching term to
describe any defined adverse toxicity metric. To standardize
the nomenclature and provide a more generally applicable
terminology, we will refer to such data as the internal effect
concentration (IEC) or for mortality endpoints correspond-
ingly internal lethal concentration (ILC), and indicate the
critical or lethal endpoint as subscript. IEC and ILC values are
typically given in units of mol or mg toxicant per kgwet weight
of the animal or tissue.
The general terms IEC and ILC are used synonymously
with CBR and LBB, respectively, unless the type of effect is
Figure 1. Toxicokinetic processes that determine the internal and target site
concentrations of a toxicant. Note that for any given toxicant, multiple
compartments and multiple target sites are possible. Very simple case of a
single target site. Role of toxicodynamics is also indicated. Adapted with
permission from Environ Sci Technol 36:1971–1979. Copyright 2002 American
Chemical Society.
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further characterized. Any external effect endpoint ECp or
LCp, where p stands for p% effect, can thus be converted to
the corresponding internal effect concentration eliciting p%
effect, IECp, or ILCp with knowledge of the ratio of external
to internal concentrations. These values are equivalent to the
commonly used term effective residue for p% effect, ERp.
Thus, for example, ILC50 or LR50 refers to the internal
concentration that is lethal to 50% of the test organisms and is
analogous to the external LC50, which is defined as the
aqueous concentration lethal to 50% of the test organisms. As
another example of the nomenclature, the IEC05 refers to the
internal effective concentration that induces a 5% effect in the
population of test organisms. This benchmark of 5% effect
cannot be measured but must be deduced from a full dose-
response curve.
If internal effect concentrations are normalized to a target
tissue concentration, this is indicated by a subscript; for
example, IEC50membrane lipid refers to the internal effect
concentration in the membrane lipids that induces a 50%
effect.
CLASSIFICATION OF MECHANISMS AND MODES OF
TOXIC ACTION
The interaction of a toxicant with biomolecules at the
target site triggers the toxic action (Figure 2). The type and
degree of interaction determine the primary action or primary
effect that characterizes the toxic mechanism. The cell or
organism may respond to this interaction with various
detoxification and defense mechanisms (e.g., induction of
multifunctional oxidases [MFO] or metallothioneines), but
ultimately secondary actions or secondary effects are observ-
able (Escher and Hermens 2002). These observable secondary
actions are called modes of toxic action. In principle, the
observable secondary actions should be directly proportional
to the primary actions, unless delayed induction or break-
down of detoxification and defense mechanisms lead to a
nonproportionality between primary and secondary actions.
In many published studies, this proportionality is assumed to
hold. This is also the likely reason for confusion in the
literature regarding the terminology between mechanism and
mode of action, with the result that both terms are often used
synonymously. For clarity, we try to differentiate systemati-
cally between the 2 terms as they are defined in Figure 2;
however, the differentiation is sometimes ambiguous even in
the proposed framework.
In addition, indirect or delayed effects, or both, may
develop. We call these tertiary effects after prolonged
exposure to toxicants. These tertiary actions are difficult to
quantify and to relate mechanistically to the primary and
secondary actions. One example would be a baseline toxicant
that produces drowsiness (secondary action), which results in
a decreased ability to seek shelter from predators leading to
premature death (tertiary action). A tertiary action could also
be an irreversible change in the health of an organism that
results indirectly from a reversible mode of action, which
nevertheless induces additional indirect effects under pro-
longed exposure. For simplicity, we focus in the present work
on primary and secondary effects.
The dynamic energy budget theory (DEBtox) (Kooijman
2000) also uses the term ‘‘physiological mode of action’’
to translate from body residues (at the target site, or
inhibition of a target molecule) to effects on life history
traits, such as feeding, growth, development, reproduction,
and survival (Alda Alvarez et al. 2006). According to this
view, each physiological mode of action has a specific effect
on the life cycle of an organism, and compounds may
exhibit the same molecular mechanism but differ in their
physiological mode of action in different organisms (Alda
Alvarez et al. 2006). Neuwo¨hner et al. (2008, 2009)
have taken up this terminology to define physiological
modes of action in algae, which group endpoints that lead
to the same physiological effect (e.g., inhibition of cell
division).
Very recently, Ankley et al. (2010) proposed a novel
conceptual framework, the ‘‘adverse outcome pathways,’’
which is based on the ‘‘toxicity pathways’’ defined for human
toxicology (National Toxicology Program 2004; Collins et al.
2008) and which is consistent with, but more detailed than,
the general outline displayed in Figure 2. In this concept,
primary and secondary actions are termed ‘‘toxicity path-
ways’’ and are linked to tertiary actions, which are termed
‘‘adverse outcome’’ at the organism or population level,
through a cascade of events from cellular response to organ
response and finally organism and population response
(Ankley et al. 2010). This concept is useful for translating
mechanistic information into endpoints meaningful for risk
assessment and may help to rationalize previously published
schemes for MoOA classification. Table 1 provides an
overview and compares the classification schemes used in
the literature.
One approach to MoOA classification is to start from the
observable symptoms and effects and relate them back to the
underlying modes of action. Researchers at EPA Duluth took
this approach when they developed so-called ‘‘fish acute
toxicity syndromes’’ (FATS). Discriminant function analysis
of physiological (McKim et al. 1987b) and behavioral
(Drummond et al. 1990) responses of fish, such as heart rate
or locomotive activity, resulted in a classification scheme of 8
Figure 2. Relationship between toxic mechanism of action, mode of action, and tertiary action.
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modes of toxic action (McKim et al. 1987a); these are listed in
Table 1.
Verhaar and Hermens and colleagues (Verhaar et al. 1992,
1996) used quantitative structure–activity relationship
(QSAR) analysis to differentiate between nonspecifically
acting, specifically acting, and reactive compounds. In their
scheme, nonspecific mechanisms (baseline toxicants) encom-
pass nonpolar and polar narcosis. Nonpolar compounds
conform to a QSAR that follows minimal toxicity, with all
other mechanisms yielding higher toxicity compared with this
QSAR. Polar narcotic compounds are 5 to 10 times more
toxic than estimated by the baseline toxicity QSAR and
specifically acting and reactive compounds are 10 to 10 000
more toxic (Verhaar et al. 1992, 1996). The latter 2 classes
cannot be differentiated by QSAR analysis but structural rules
serve to differentiate reactive and specifically acting com-
pounds.
Nendza and Wenzel proposed a similar classification
scheme based on ecotoxicity profiles and QSAR analysis
(Nendza et al. 1995; Nendza and Wenzel 2006), which falls
somewhere between the FATS approach (but extended to
organisms other than fish) and the chemical structure-
oriented approach (Verhaar et al. 1992, 1996; Bradbury
1994).
An alternative, bottom-up approach starts by identifying
the molecular interaction a toxicant may have with its target
molecules or sites (Escher and Hermens 2002). This approach
accounts not only for the chemical structure of the toxicant
but also for the target, and it relies on simple rules for defining
the interactions between toxicant and target. The main targets
for toxicants are membrane lipids, proteins and peptides, and
DNA. Depending on the type of interaction with the target, it
is possible to differentiate between nonspecific effects, when
only partitioning to the target site is involved, and specific
effects, when interactions between the toxicant and a target
molecule are often sterically directed and include specific H-
donor/acceptor interactions as well as ionic interactions. If
covalent bonds are formed between the toxicant and target,
these are referred to as reactive mechanisms (Escher and
Hermens 2002). This generic classification scheme can be
further refined by differentiation between more specialized
target sites, as shown in Table 1. For example, we can
associate toxic mechanisms with proteins and peptides in
general, but we can also associate them with specific enzymes
and receptors. The first concerns general electrophilic
reactivity resulting in the alkylation and oxidation of proteins
and related modes of action such as glutathione depletion and
the breakdown of the cellular defense system against oxidants.
A myriad of specific enzymes and receptors can be described,
each of which refers to a specific biochemical process, whose
disturbance is related to 1 primary mechanism and corre-
sponding mode of action. Table 1 provides an overview of this
classification scheme (Escher and Hermens 2002) and
compares it with the other classification schemes available
in literature.
Another factor that should be considered is the abundance
and activity of receptors that vary between various organs. For
example, in most vertebrates the predominant organ asso-
ciated with biotransformation of toxicants is the liver.
Biotransformation does occur in all the tissue types tested;
however, extrahepatic tissues (nonliver tissue) have a limited
number of enzymes and thus can only biotransform a limited
diversity of chemicals (Amdur et al. 1991). These extra-
hepatic enzymes also generally have lower activities. The
relative capacity of some organs to biotransform toxicants can
be characterized in 3 categories: liver (high); lung, kidney, and
intestine (medium); and skin, testes, placenta, and adrenals
(low) (Amdur et al. 1991). Whereas extrahepatic biotrans-
formation may not contribute significantly to biotransforma-
tion as a whole, this is a major factor in toxicant-induced
tissue injury.
It is also important to differentiate between reversible and
irreversible mechanisms of action. Reversible mechanisms can
be related to internal effect concentrations that may or may
not be constant over time. In contrast, irreversible mecha-
nisms need other indicators to describe the internal dose
metric, for example, a critical depletion rate of a receptor, a
critical level (fraction) of affected receptor, or a critical
reaction rate for the reaction between toxicant and its target
(site). Differing degrees of reversibility can be accommodated
by toxicodynamic modeling (Ashauer and Brown 2008).
Baseline toxicity
Baseline toxicity is believed to be a result of the nonspecific
disturbance of the integrity and functioning of cell mem-
branes as a result of chemicals (typically organic pollutants)
partitioning into biological cell membranes (Ko¨nemann 1981;
Veith et al. 1983; Lipnick 1989; Warne et al. 1991; van
Wezel and Opperhuizen 1995; Mackay et al. 2009).
Chemicals in the membrane are not bound covalently to the
membrane but rather are ‘‘dissolved’’ in it. Baseline toxicity
caused by the presence of chemicals in the membrane is a
reversible mechanism, as was recognized by Meyer and
Overton independently more than a century ago (Meyer
1899; Overton 1899). When a cell membrane with baseline
toxicants is brought into contact with a medium exhibiting
lower fugacity with respect to the toxicant (e.g., transferring
an animal from water containing the toxicant to pure water),
the toxicant will diffuse out of the membrane, giving the
organism a chance to recover rapidly. Note that the
reversibility depends on the aqueous solubility and hydro-
phobicity of a given compound because compounds with
limited solubility diffuse to water slowly. Also, this process
depends on the physiological status; organisms that are
immobilized by baseline toxicants have very slow respiration
that limits the diffusion to the excretory membrane,
increasing the time to recovery.
With respect to reversibility, baseline toxicity is analogous
to the pharmacological mechanism by which anesthetic drugs
work (Lipnick 1989; Antkowiak 2001; Moody and Skolnick
2001). The high degree of reversibility of the mechanism
means that toxicodynamic recovery is rapid. In fact, it is often
assumed that baseline toxicity is instantaneously reversible
(i.e., that the effect decreases directly in proportion to the
removal of the toxicant from the membrane, without delay).
Based on this information, the choice of effect models needs
to correspond to this characteristic of baseline toxicity. The
nonspecific nature of the mechanism (i.e., partitioning into
phospholipid membranes) means that differences between
individuals or species are relatively small. Anesthetists and
ecotoxicologists both observed a very narrow range of
concentrations in the membranes of different patients or
species, which cause a given narcotic or baseline toxic
response (Seeman et al. 1971; van Wezel and Opperhuizen
1995; Escher and Schwarzenbach 2002).
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Much of the knowledge drawn from pharmacology is
relevant in ecotoxicology; therefore, narcosis is a term often
used as a synonym for baseline toxicity. We avoid the terms
narcosis and anesthesia here because in pharmacology they
are used mainly within the context of nerve cells and specific
interactions with receptors. Ligand-gated ion channels are the
most important target sites for anesthetics in the mammalian
central nervous system because they play a key role in
neuronal information processing. At higher concentration, a
variety of other hydrophobic sites, the interfaces between
membrane proteins and the membrane, are also affected
(Sandermann 1993; Franks et al. 1994; Krasowski et al. 1999;
Antkowiak 2001; Moody and Skolnick 2001).
Although quite a few studies have been conducted on
baseline toxicity in ecotoxicology, some unanswered ques-
tions remain. In particular, the question of the underlying
molecular mechanism of baseline toxicity has not been
resolved conclusively. It is commonly accepted that the
membrane disturbance is caused by the accumulation of
environmental pollutants in hydrophobic phases within the
organism, such as membrane lipids (van Wezel and Opper-
huizen 1995). Some alternative explanations such as specific
protein interactions have also been proposed (Franks et al.
1990).
When narcotic effects are correlated with the octanol–
water partition coefficient (KOW) as a measure of hydro-
phobicity, regression equations are found to be significantly
different for nonpolar and polar chemicals. On the basis of
this finding, it was concluded that 2 mechanisms, i.e.,
nonpolar and polar narcosis, could be distinguished (Veith
and Broderius 1990; Verhaar et al. 1996).
Later studies, however, indicated that the difference
between nonpolar and polar narcosis was due to the
inappropriate choice of log KOW, which underestimates the
partitioning of polar narcotic compounds between phospho-
lipid cell membranes and water (Vaes et al. 1997, 1998).
With the liposome–water distribution coefficient (logKlipw)
instead of log KOW as the descriptor, QSARs fall on a single
line for a series of polar and nonpolar narcotics, suggesting a
common mode of action for polar and nonpolar narcotics
(Vaes et al. 1998). Urrestarazu Ramos et al. (1998) proposed
a mechanistic model for baseline toxicity whereby the
toxicant accumulates at the interface between the membrane
and the aqueous phase. This hypothesis is supported by
molecular dynamics calculations and rationalizes the impor-
tance of H-donor–acceptor interactions.
Variability in bioaccumulation between chemicals that act
as baseline toxicants has been shown to explain much of the
variability in external effect concentrations (McKim and
Schmeider 1991; McCarty and Mackay 1993, McCarty et al.
1993). The product of the bioconcentration factor (BCF) and
the lethal concentration in the aqueous phase (LC50) was
found to be constant for a large number of chemicals; it is
therefore commonly referred to as internal lethal concen-
tration (ILC50), used synonymously with lethal residue
(LR50) or lethal body burden (LBB). Measured LLBs
determined for a series of nonpolar and polar narcotics in
fish differed significantly (van Wezel and Opperhuizen 1995);
that is, polar narcotic chemicals appeared to have a higher
intrinsic toxicity than that of nonpolar narcotics. However,
van Wezel and Opperhuizen (1995) attributed the higher
intrinsic toxicity of polar narcotics to their different accumu-
lation behavior into nontarget cell constituents as compared
with target lipids. This proposal was subsequently shown to
be correct by Roberts and Costello (2003), who argued that
polar and nonpolar organic compounds still have somewhat
different underlying mechanisms because polar compounds
intercalate less deeply into membranes and bind via H-bonds
to polar head groups of the membrane (2-dimensional
partitioning), in contrast to nonpolar compounds, which
intercalate deeper into the membrane and can move in all
directions in the hydrocarbon core of the membrane (Roberts
et al. 2003). Nevertheless, research has shown no clear-cut
categorization between nonpolar and polar compounds;
rather, there is a gradual transition of polarity.
Membrane concentrations can be modeled via body
residues when considering variable amounts of target tissue
(van Wezel and Opperhuizen 1995; Vaes et al. 1998).
Unfortunately, it is not possible to differentiate between
target tissue (membranes) and nontarget storage lipids in a
whole organism because the 2 lipid types cannot be separated
quantitatively without disturbing the toxicant concentration.
To address this concept, Escher et al. (2002) proposed an in
vitro test system based on isolated energy-transducing
membrane vesicles that permits a direct estimate of the
membrane burden of baseline toxicants. These membrane
vesicles contain approximately 30% membrane lipids (dry
weight basis) with the remainder as functional proteins. Thus,
no storage lipids are involved. Baseline toxicity can be
quantified in such an in vitro system by the spectroscopic
quantification of the membrane potential, which is destroyed
in the presence of baseline toxicants. The results of this study
clearly indicated that there are equal effective membrane
concentrations of nonpolar and polar compounds on the order
of 220 to 470 mmol/kglip (Escher et al. 2002), confirming the
hypothesis of van Wezel and Opperhuizen (1995) and
supporting the work of Vaes et al. (1998).
These results encouraged further modeling studies and a
large data set of measured total internal effect concentrations
from various literature sources was modeled with a simple 3-
compartment model (Eqn. 1).
IECmembrane lipid
¼ IECtotal  Klipw
fw þ fmembrane lipid  Klipw þ fstorage lipid  Khw
ð1Þ
The model assumed that each aquatic organism was
composed of membrane lipids, storage lipid, and a water-
like compartment (Escher and Schwarzenbach 2002). The
liposome–water partition coefficient Klipw serves as the model
parameter to model uptake into membrane lipids; the
hexane–water partition coefficient Khw serves as model
parameter to model uptake into storage lipids. Parameters
fw, fmembrane lipid, and fstorage lipid describe the fraction of
chemicals in water, storage lipids, and membrane lipids,
respectively. Figure 3 illustrates this simple model for fish and
depicts a compilation of results (details can be found in
Escher and Schwarzenbach 2002).
As is evident from Figure 3, the total internal effect
concentration IECtotal given in units of mmol/kgwet weight is
slightly higher for nonpolar than for polar compounds. This
difference led initially to the hypothesis that there are 2
different types of narcotic mechanisms (McKim et al. 1987a).
However, the small difference in IECtotal is attributable to a
large difference in IECstorage lipids between nonpolar and polar
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compounds, whereas the modeled membrane burdens
(IECmembrane in units of mmol/kglip) are equal for polar and
nonpolar compounds, confirming that there is no difference in
toxic mechanism between polar and nonpolar compounds
(Vaes et al. 1998).
The database for aquatic organisms is much weaker other
than for fish. However, in principle, the same modeling
approach can also be taken for algae and Daphnia. The
problem is that fewer studies are available that have measured
the lipid content of algae and Daphnia at the same time as the
toxicity studies, so assumptions regarding the lipid content
must be derived from other studies. Figure 4 illustrates that
even between different aquatic species there is no significant
difference between the target–lipid normalized IECmembrane
lipid, even if effects were assessed at different times and life
stages. Again, the concentration of toxicant in storage lipid
varies over several orders of magnitude between polar and
nonpolar compounds for Daphnia, too, but for algae no
storage lipids are included. Hendriks et al. (2005) extended
the data set to additional aquatic species, including plants,
annelids, mollusks, and arthropods, and found a consistent
picture when modeling target lipid concentrations. These
examples demonstrate that even for a very simple mecha-
nism, such as baseline toxicity, total lipid normalized internal
concentration is not a perfect surrogate for the concentration
at the target site in the membrane because of subtle
differences in partitioning between lipid bilayers and bulk
storage lipids.
Several studies have shown that under laboratory con-
ditions, the ILC of baseline toxicants that leads to mortality of
the test organism is constant in time and that this is not
dependent on the exposure time (Leslie et al. 2004, and
references therein, e.g., Abernethy et al. 1988; Warne et al.
1991; McCarty and Mackay 1993). In these tests, organisms
began to absorb the chemical from their surroundings in a
process driven by a combination of the fugacity gradient and
the relatively large affinity of the chemical for the organism.
The organisms continued to absorb the chemical until steady
state or death was reached, whichever came first. Accord-
ingly, the time dependence of toxicity of baseline toxicants
can be described by a simple toxicokinetic model that
assumes bioconcentration as a first-order kinetics 1-compart-
ment model and a constant body residue for the same effect
level, independent of exposure duration (constant ILC) after
toxicokinetic steady state is obtained (van Hoogen and
Opperhuizen 1988). The baseline effect is instantaneously
reversible, so the time course of effects is governed purely by
toxicokinetics for nonconstant exposure conditions. A more
detailed discussion on toxicokinetic models can be found
below.
The literature does contain studies, however, asserting that
baseline toxicants have a second kinetic step, i.e., that internal
effect concentrations do not remain constant over time
(Chaisuksant et al. 1997, 1999; Lee et al. 2002; 2003). In
fact, these articles reported that the closer the exposure time
gets to the life span of the organism, the smaller the ILC50
(Chaisuksant et al. 1999).
As exposure time is prolonged, tertiary effects could arise
after the primary effect (disturbance of the membrane) and
secondary effect (narcosis) occurred, even for baseline
toxicants. These effects could be postulated to arise not from
increased damage to the membrane (the site of action) over
time, but from effects on an organism’s life caused by
suppression of the central nervous system associated with
Figure 3. Three-compartmentmodel to assess the target site concentration of baseline toxicants. Data andmodel taken from Escher and Schwarzenbach (2002).
Graph shows boxes, which extend from the 25th to the 75th percentile, with a horizontal line marking the median. Whiskers extend above and below the boxes
to the highest and lowest value. Number of data points is 19 for nonpolar compounds and 14 for polar compounds. f¼ fraction of lipid.
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narcosis. In the field, prolonged exposure could result in loss
of alertness, leading to increased predation, modified behav-
ior, delayed or inhibited mating, and decreased ability to find
sufficient food (indirect or tertiary effects).
It is important to note that the internal concentrations
required to elicit baseline toxicity are relatively high, in the
range of 50 mmol/kgmembrane lipid (see data shown in Figure 3).
At the IEC50membrane lipids, the toxicant will be 1% to 2.5% of
the membrane (see also Abernethy et al. 1988), and we can
expect membrane expansion and other related effects. Also,
with membrane burdens so high, it is sometimes difficult to
reach them in an experiment with a single chemical, and such
measurements are highly prone to artifacts.
Despite the limitations described above, the baseline
toxicity concept is very useful in developing a conceptual
understanding of the toxic effects of mixtures. As discussed in
greater detail in the accompanying article on mixture toxicity
(Dyer et al. 2011), the toxicity of mixtures of chemicals each
with baseline toxicity is always internal-concentration addi-
tive. In addition, for mixtures of large numbers of compounds
with various different mechanisms, it is likely that the specific
effects of specific components of the mixture do not
dominate, but the additive effect on the underlying baseline
toxicity dominates the overall mixture effect (Hermens et al.
1982; Warne and Hawker 1995).
Tissue residues for compounds eliciting specific molecular
mechanisms
Target tissue residues are more uniform over species and
time than are aqueous effect concentrations because they
account for differences in toxicokinetics between different
species. In general, the IECs of specifically acting and reactive
compounds are lower than those of baseline toxicants and
appear to vary more between different aquatic species. (See
Figure 5, which shows experimental data from the literature
compiled by Hendriks et al. 2005.) Line a in Figure 5 refers to
a compilation by the authors of the study from various
literature sources; line b refers to the compilation of fish data
by McCarty and Mackay (1993). Line c in Figure 5 is an
extremely diverse compilation of literature data by Barron
et al. (2002) (hence the much wider ranges than for the other
data compilations), and line d represents data from the
Environmental Residue/Effects Database ([ERED] http://
www.wes.army.mil/el/ered/index.html) compiled by Traas
et al. (2004). Note that this database is based on MoOA, and
not on primary mechanisms; this contributes to the increased
variability because several different molecular mechanisms
(MeOA) can be integrated under 1 MoOA. In addition,
multiple responses are combined, contributing to the
variability.
The greater variability within and between the different
specific MoOAs stems from differences in toxicodynamics.
For baseline toxicants, the effective target concentration is
essentially equivalent for every chemical. Specifically acting
and reactive compounds have different total internal and
target site concentrations for different MoOAs, and even
within a given MeOA, because the intrinsic potency might
vary. For example, the same concentration at the target site
may produce a high variability in toxic response among
individuals or species. An example of this is uncoupling of
oxidative phosphorylation. For this MoOA, the potency of an
uncoupler is determined by the concentration at the target
site in addition to the energy barrier for crossing the energy-
transducing membrane (Spycher et al. 2008). Studies with
compounds inhibiting acetylcholinesterase irreversibly pro-
vide further evidence that toxic effects for those specifically
acting compounds cannot be explained by internal concen-
trations (Ashauer et al. 2010b).
Differences in the sensitivity of organisms to a toxicant can
arise through 2 means. First is the presence or absence of the
target site required for the MeOA to exert its effects. Second,
differences in the quantity and activity of the target site and/
or defense mechanisms can modify the MoOA and thus the
overall sensitivity, even though the toxicant exerts its effect
by the same molecular mechanism (Escher and Hermens
2002). An example of the former is herbicides that will
manifest their specific MeOA in photosynthetic organisms
but that act by a nonspecific MoOA for organisms without
photosynthetic systems. Life stage differences within a species
is another consideration. For example, enzyme systems such
as CYP1A or PCY450 may not be fully expressed in the egg
but may be present in the adult. Consequently, whole-body
toxicity metrics for chemicals with specific MeOAs are less
adequate surrogates for toxicity based on target tissue
concentrations than are observed for chemicals exhibiting
baseline toxicity. However, given the drawbacks, these
metrics are acceptable surrogates in many instances.
In addition, although baseline toxicity is fully reversible
(unless tertiary irreversible damage arises in other targets as a
result of prolonged exposure), specific and reactive MeOAs
differ in their degree and speed of reversibility. Typically for
compounds with reversible MeOAs, the effects are instanta-
neous and responses are observed if a critical concentration of
affected target site molecules is produced. The importance of
Figure 4. Comparison of IEC50membrane lipid (mmol/kglip) and IEC50storage lipid
(mmol/kglip) of polar and nonpolar narcotic chemicals in algae (membrane
lipid only), daphnids, fish, and the Kinspec system (membrane lipids only).
Graph shows boxes, which extend from the 25th to the 75th percentile, with a
horizontal line marking the median. Whiskers extend above and below the
boxes to the highest and lowest value. Graph modified from and data
compiled by Escher and Schwarzenbach (2002).
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toxicodynamics depends on the speed and reversibility of
both the MeOA and MoOA (Ashauer and Brown 2008).
Time dependence of the effect of quickly and fully reversibly
acting toxicants may be dominated by toxicokinetics; how-
ever, toxicodynamics may play an additional role for MeOAs
characterized by slow or incomplete reversibility. Concep-
tually, this can be visualized by a gradual occupation of target
sites and, in the case of fluctuating or pulsed exposure
concentrations, regeneration of target sites. If a critical
concentration of toxicant is reached at the target site (i.e., a
critical percentage of target sites are occupied) for a critical
duration, a toxic effect is elicited.
The intrinsic potency of a toxicant can be expressed by the
toxic ratio (TR) (Eqn. 2) (previously called the excess
toxicity, Te), which is the ratio between the predicted IEC
for baseline toxicity to the experimental IEC (Lipnick et al.
1987). We have modified this equation for internal concen-
tration as follows:
TR ¼ ECbaseline toxicity;QSAR
ECexperimental
¼ BCF  ECbaseline toxicity;QSAR
BCF  ECexperimental
¼ IECbaselinetoxicity;QSAR
IECexperimental
: ð2Þ
The external concentration-based EC for baseline toxicity
can be predicted using a QSAR for baseline toxicity. The TR
for a compound derived using the external effect concen-
trations (EC) or the internal effect concentrations (IEC) will
be the same because the IEC is related to the EC via the BCF.
For the TR, using internal concentration, the BCF terms
cancel out. This simplified picture holds only for non-
metabolizable compounds. In addition to biotransformation,
deviations may also occur if accumulation in compartments
other than storage lipids is important, which is the case for
lean organisms or substances with affinity for proteins. The
latter issue can be addressed by a slightly more detailed
modeling effort that relates the affinity of substances with
specific compartments (e.g., polar lipids, neutral lipids,
proteins, lignin) using the appropriate partition coefficients
(Escher and Hermens 2002).
The intrinsic potency of a reactive compound will depend
on parameters such as the tendency to react with a specific
biological molecule (selectivity) and the rate of reaction
(sensitivity). For reactive toxicants with selective reactivity in
particular, this tendency is related to the electrophilicity and
nucleophilicity of the toxicant. For specifically acting com-
pounds, intrinsic potency depends on the affinity for
(selectivity) and type of interaction with (sensitivity) a
receptor or a target enzyme.
Reversible specific mechanisms
For completely and instantaneously reversible specific
mechanisms, the effective or critical target concentrations
should be uniform for a given toxicant and should not depend
on exposure time, but they do differ for different chemicals.
Examples include inhibitors of Photosystem II (PSII) such as
phenylureas and triazines. Each PSII inhibitor has a different
affinity to the target site, but the effects are rapid and
reversible; thus the total internal concentration is relatively
invariant over an extended period of time. Complete recovery
of algal photosynthetic activity has been observed after
treatment with short pulses of PSII inhibitors (Vallotton
et al. 2008). As for baseline toxicants, any time dependence of
toxicity is explained mainly by the elimination kinetics. Slow
elimination kinetics dictates the degree of reversibility and the
rate at which the organism reaches equilibrium. With very
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Figure 5. Total tissue internal effect concentrations IECtotal (mol/kgwet weight) for various species and 9 different mechanisms of action (MoOAs) Lines a–d within
the data for each MoOA refer to data compilations for different species; a- drawn line: data compiled by (Hendriks et al. 2005); b- dotted line: data compiled by
(McCarty et al. 1993), c-dashed line: data compiled by (Barron et al. 2002), and d- thinner drawn line: data compiled by (Traas et al. 2004); a and d represent 5 to
95 percentiles, and b and c are the minimum andmaximum values. Adapted with permission from Environ Sci Technol 39:3226–3236. Copyright 2005 American
Chemical Society.
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prolonged exposure (i.e., approaching the life span of the
organism), tertiary effects may cause the critical target
concentration for each chemical to vary, as was noted by
(Chaisuksant et al. 1997; Yu et al. 1999; Lee et al. 2002).
Another example of reversible specifically acting com-
pounds are uncouplers of oxidative phosphorylation, in
particular the protonophoric uncouplers like the weak
phenolic acids pentachlorophenol or dinoseb (2-sec-butyl-
4,6-dinitrophenol). These compounds destroy the electro-
chemical proton gradient, which delivers energy to the ATP
synthesis biochemical reactions by transporting protons across
the membrane. The uncoupling activity is dependent on the
abundance of uncouplers in the energy-transducing mem-
branes but also on the speciation of the weak organic acid.
This is because both the neutral acidic and the charged basic
species need to be present for efficient uncoupling (Terada
1990), resulting in a strong dependence of uncoupling
activity on pH (Escher et al. 1999). Even if 2 uncouplers
are present in the membrane at equal concentrations and
equal ratios of the acidic and basic species, intrinsic potency
differences can remain. The intrinsic potency of an uncoupler
is determined by the membrane permeability of both
neutral and charged species. If the energy barrier of the
charged species for crossing the membrane is too high,
uncoupling will be slow and uncoupling inefficient (Spycher
et al. 2005).
For partially reversible mechanisms with noninstantaneous
reversibility, both the critical target site concentration as well
as the exposure duration matter. Acetylcholine esterase
inhibitors illustrate this case. Whereas carbamates bind
reversibly to the target site, the enzyme acetylcholine esterase
(AChE), the binding of organophosphates is rapid but the
release is slow, especially if the enzyme–inhibitor complex
‘‘ages,’’ i.e., further ester groups hydrolyze (Timbrell 2000).
Therefore, organophosphates are considered irreversibly act-
ing AChE inhibitors (Legierse et al. 1999), and carbamates
are considered reversibly acting AChE inhibitors.
Irreversible specific mechanisms
For irreversible specific and reactive mechanisms, the time
dependence of effects is more complex and will not be
explored in this review. For these situations, the time integral
of occupied targets might be a better internal exposure
parameter than the equilibrium target concentration. For
such mechanisms, there may be no constant critical IEC
because of the considerable dependence on exposure dura-
tion, but other parameters may still serve the purpose of
defining effects in an independent way, such as the reaction
rate with the target site. Returning to the example of the
AChE inhibitors, Legierse et al. (1999) proposed as an
alternative measure of target occupation the critical area
under the curve (CAUC), i.e., the time-integrated internal
concentration. The toxic effect occurs at a defined CAUC,
and this can be associated with a higher exposure concen-
tration over a shorter time or a lower exposure concentration
over longer time, as illustrated in Figure 6. With this model, it
was possible to rationalize the time dependence of toxicity of
a series of irreversible AChE inhibitors in various organisms,
such as chlorothion in the pond snail and methidathion in
guppy (Legierse et al. 1999). CAUC is approximately
constant for a single compound but varies between different
compounds because of differences in intrinsic potency.
Despite the additional complexity when dealing with
irreversible specific mechanisms, the TRA facilitates charac-
terization of the exposure at the target sites. Hence it is still
useful in analyzing the time dependence of, and relationship
between, occupied target sites and elicited toxic effects.
Reactive mechanisms
Reactive mechanisms refer to electrophilic reactivity
toward biological nucleophiles such as proteins and DNA,
or to effects related to oxidative stress. Oxidative stress is a
cascade of events that are too difficult to describe with the
approaches presented in the present work (or again, specific
surrogate measures have to be defined). However, the
electrophilic reactivity toward biological nucleophiles can be
explained in a straightforward manner if one assumes a critical
target reaction rate (Verhaar et al. 1999).
For reactive chemicals there is again no critical tissue
residue because the toxicants may react directly with their
biological targets in such a manner that the compound may
not even be detected in the tissue. In such cases, the critical
reaction rate with the target site and the depletion of
unoccupied target sites are alternative measures of internal
exposure, and the critical target occupation (CTO) model can
also be applied to reactive mechanisms (Verhaar et al. 1999).
Reactive mechanisms involve the formation of covalent bonds
and are generally irreversible.
Freidig et al. (1999) measured the depletion rate of
glutathione in an in vitro system and used this indicator to
rank the toxic potencies of a series of acrylates. By comparing
the depletion rates with fish LC50 data, a critical depletion
rate was defined. This approach was successful because the
site of action in the in vitro system as well as in vivo is situated
in the aqueous phase, making exposure in both systems very
similar. Another major advantage of such an approach is that
the total response reflects the overall toxicity of a mixture of
the reactive acrylates in a similar way as total body residue
does for narcosis.
Harder, Escher, and Schwarzenbach (2003) built on this
work and proposed to use the reaction rates of electrophilic
chemicals toward model biological nucleophiles as indicators
of toxicity. The model nucleophiles were deoxyguanosine and
glutathione, which served as surrogates for DNA bases and
proteins and/or peptides. The reaction rates allowed an
Figure 6. Critical target occupation model. Measure of effect is the time-
integral of the internal concentration, the so-called critical area under the
curve (CAUC). Adapted with permission from Environ Sci Technol 33:917–925.
Copyright 1999 American Chemical Society.
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estimate of the toxic potency, but also a classification
according to the selectivity of the electrophilic reaction
(Harder, Escher, Landini, et al. 2003; Harder, Escher,
Schwarzenbach 2003). Whereas soft electrophiles like acryl-
ates are more reactive with proteins and peptides, hard
electrophiles like styrene oxide react with the DNA bases.
Chemicals with more than one mode of action
Chemicals may have more than one mechanism and mode
of action. The most well-known example for multiple MoOA
is that some specific-acting organic chemicals may contribute
to baseline toxicity. In many cases, this baseline toxicity is
overwhelmed by a specific mechanism of action, and baseline
toxicity action will not be apparent. The TR can be used as an
indicator for the potential contribution of baseline toxicity
when examining TR-based toxicity data. If the TR is >10,
baseline toxicity does not play a role at all in a toxicity test
with individual organisms. But if the TR is closer to 1,
baseline toxicity will become part of the overall effect.
Baseline toxicity can become relevant in several cases. One
interesting example is when the concentration of a reactive or
specifically acting chemical at the site of action in a hydro-
philic environment is too low to exert the specific toxicity.
This will be applicable for more hydrophobic reactive
chemicals because their concentrations in a more hydro-
phobic environment (e.g., the cell membrane) will be
relatively high. In such cases, the less intrinsically potent
baseline effect will dominate the reactive toxicity. Several
examples of studies with reactive chemicals support this
interesting hypothesis. Experimental toxicity data for less
hydrophobic reactive chemicals often have relatively high TR
values, whereas the TR for the more hydrophobic reactive
compounds are often lower and approach 1 (Deneer, Seinen,
Hermens 1988a; Deneer, Sinnige, et al. 1988b; Freidig et al.
1999). This same trend is observed for organophosphates
(Freidig and Hermens 2001) (Table 2). The TR is close to 1
for the 3 most hydrophobic (and thus sterically bulky)
organophosphates (iodophenphos, bromophos, and ronnel),
and these compounds most likely act via the baseline toxicity
mechanism. The 3 other organophosphates (fenitrothion,
methylparathion, and malathion) are less hydrophobic, and
the TR is much higher. The toxic mechanism of these
chemicals is likely to be predominantly by their specific
MeOA, i.e., inhibition of acetylcholine esterase (AChE).
A second example occurs in complex mixtures with
numerous different chemicals when the small contribution
by the baseline toxicity of each chemical may lead to a
significant toxic effect; this is because baseline toxicity is
always concentration additive and different specific MoOAs
are not (Warne and Hawker 1995). Dyer et al. (2011) present
a more thorough discussion of this phenomenon. The
advantage of using the internal effect concentrations is that
in mixtures the body residues can simply be added up. Earlier
work has shown that in LC50 tests for equitoxic mixtures (all
mixture components present in concentrations that elicit the
same contribution to the mixture effect) of 8 to 24 chemicals
with specific MeOAs, the contribution of the baseline toxicity
MeOA can be up to 30% (Hermens et al. 1982).
As a third example, if the potency for the specific MeOA is
not much higher than the potency for baseline toxicity, this
second MeOA will contribute significantly to the overall
effect. For example, the mechanism of protonophoric
uncoupling (MoOA uncoupling of oxidative phosphoryla-
tion) changes into baseline toxicity when at the pH of the
experiment the neutral species dominates the charged species
(Escher et al. 1999; Escher and Schwarzenbach 2002).
Finally, time may be a factor. In some cases, it may take
longer for the response to develop for 1 MeOA compared
with another.
Another interesting example of chemicals having multiple
MoOAs is the lethal toxicity of organotin compounds that are
respiratory uncouplers and respiratory inhibitors. However, in
practice it is difficult to differentiate between these 2 modes
of action and assess which is dominant because of mitigating
factors. First, the underlying toxic mechanisms occur at
energy-transducing membranes such as mitochondrial mem-
branes or photosynthetic membranes. Second, different
mechanisms are possible that could underlie the observed
MoOAs. By using isolated membrane vesicles of a photo-
synthetic bacterium as test system, it was possible to
differentiate between uncoupling by a hydroxide uniport
mechanism and direct inhibition of the ATP synthetase
(Hunziker et al. 2002). The result of this study clearly
indicated that the acute effect of tributyltin is dominated by
uncoupling, whereas the acute effect of triphenyltin is
dominated by direct inhibition of ATP synthetase (Hunziker
et al. 2002). This difference can again be explained in terms of
the affinity of the 2 organotin compounds for the target sites.
The membrane–water partitioning of tributyltin follows its
hydrophobicity and is consequently driven mainly by parti-
tioning into the membrane; in contrast, triphenyltin has a
much higher affinity for membranes than would be expected
by its hydrophobicity (Hunziker et al. 2001). Triphenyltin
forms stronger complexes with oxygen ligands than tribu-
tyltin, which explains the stronger binding of triphenyltin to
membranes than can be predicted by partitioning because
binding is through complex formation, but it also explains the
higher affinity of triphenyltin to the ATP synthetase.
Consequently, triphenyltin is a more potent inhibitor of the
enzyme, and tributyltin is a more potent uncoupler. Despite
the differences in the molecular mechanism of toxicity, the
observable MoOA is the same. This example focuses on the
Table 2. Relative contribution of baseline and specific mechanisms
of action (MeOA) to the toxicity of selected organophosphates
(Freidig et al. 2001)
Organophosphate Log Kow
a TRb
Dominant toxic
mechanism
Iodophenphos 5.51 0.57 Baseline toxicity
Bromophos 5.21 1.8 Baseline toxicity
Ronnel 5.07 2.9 Baseline toxicity
Fenitrothion 3.47 7.1 Unclear
Methylparathion 3.04 41.2 AChE inhibition
Malathion 2.94 89.6 AChE inhibition
As the toxic ratios decrease to <10, the contribution of the baseline MeOA to
the toxicity increases. Once the TR is >10, the baseline MeOA contributes very
little to the toxicity of the chemical.
aKow: octanol–water partition coefficient.
bToxic ratio TR is defined by Eqn 1, where LC50baseline toxicity, QSAR was calculated
based on a QSAR for baseline toxicity for the specific organism (in this case
guppy) (Freidig et al. 2001).
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lethal action of triorganotins on energy transduction. How-
ever, the organotins exhibit additional MoOAs, as discussed
by Meador (2006), such as immunotoxicity and endocrine
disruption, through binding to the retinoid receptor (Nish-
ikawa et al. 2004).
DOSE METRICS OF INTERNAL EXPOSURE
Tissue concentrations
The internal exposure of pollutants can be determined and
expressed by several methods. Tissue concentrations on a wet
weight or dry weight basis are the most directly observable
measure of internal exposure. They are obtained by extracting
tissue samples with suitable solvent (e.g., dichloromethane
for apolar organics and hydrochloric acid for metals) followed
by instrumental analysis.
Such measured tissue concentrations can be normalized by
the lipid fraction of the tissue. At least 3 important issues
should be addressed with regard to such normalization. First,
normalization is only meaningful when the sorptive capacity
of the tissue is adequately represented by the normalizing
parameters (e.g., lipid fraction) (Schwarzenbach 2003). This
requirement is important to ensure the general agreement
between lipid-normalized concentrations and the actual
concentrations in the lipid. De Bruyn and Gobas (2007)
demonstrated that if chemicals bind to proteins, normal-
ization procedures that only consider the lipid fraction are not
sufficient. By contrast, normalizing exclusively to protein will
not work because partitioning of hydrophobic compounds to
membranes can never be neglected.
Second, normalized concentrations should also preferably
be directly related to the pollutant concentration at the target
site. It is important to realize that storage lipids often
dominate the sorptive capacity of animal tissue for many
hydrophobic chemicals, whereas lipid membranes often are
considered their target site. A mismatch between the
partitioning properties of these 2 types of lipids will thus
introduce error into the internal exposure response relation-
ship, as was discussed above.
Third, normalization procedures require measurements of
additional input parameters such as the lipid fraction and the
dry weight content. The application of these parameters
introduces additional error into the internal exposure value.
Biomimetic extractions and free concentrations
Extraction of organic contaminants from tissue remains
tedious work. The difficulty of measuring internal concen-
trations and TRs remains one of the greatest obstacles in the
application of the TRA. Internal exposure can be determined
and expressed in a number of alternative ways, including
chemical methods that mimic uptake into organisms (e.g.,
biomimetic extractions). Partitioning-based sampling techni-
ques can be tailored to mimic the uptake from the external
exposure media and into an organism. Such techniques are
often referred to as biomimetic extractions using passive
samplers. Examples of these passive samplers include C18-
coated EmporeTM disks (Verhaar et al. 1995), semipermeable
membrane devices (SPMD) (Huckins et al. 1990), solid-phase
microextraction fibers (SPME) (Leslie et al. 2002), and
polydimethylsiloxane (PMDS) (Smedes, 2007). Frequently,
the kinetics of uptake into, and elimination from, an organism
are different from the corresponding kinetics for a sampler,
and calibration is needed.
Recently, it was suggested that passive samplers be used
directly within animal tissue and body fluids. Thin polymer
coatings can be equilibrated directly with animal tissue to
determine the chemical activity or the fugacity of the
contaminant in the tissue (Wilcockson and Gobas 2001;
Ossiander et al. 2008; Jahnke et al. 2009; Mayer et al. 2009)
Diffusive sampling techniques such as SPME (Heringa et al.
2003) and microdialysis (Oravcova et al. 1996) can be applied
to measure freely dissolved concentrations in, for example,
digestive fluids and blood, which can be considered effective
concentrations for internal diffusion and partitioning proc-
esses. Information about the concentration of unbound
chemical (freely dissolved) is relevant as dose metrics in in
vitro tests (Heringa et al. 2004), as well as in the extrapolation
from in vitro biotransformation to in vivo biotransformation
(Riley et al. 2005).
Biomimetic devices provide a useful range of applicability
to compounds that are not biotransformed and reach steady
state during the exposure time of toxicity test. They fail for
those toxicants that are metabolized and those that exhibit
large variation in uptake rate across species and when uptake
is not yet in steady state at time of death (or effect).
Chemical activity and fugacity as new internal exposure
parameters
Internal exposure is generally expressed and understood as
a contaminant concentration. Alternatively, internal exposure
might also be expressed as fugacity or the unitless chemical
activity. The former expresses the escaping tendency of a
chemical into ideal gas, whereas the latter expresses the
energetic state of a chemical relative to its pure (sub)cooled
liquid. Both parameters are multimedia parameters that have
been applied in environmental fate modeling (Mackay 2004,
and references cited therein) as well as in bioavailability and
toxicological studies (Ferguson, 1939; Mayer and Reich-
enberg, 2006; Mackay et al. 2009). The strength of these
parameters within an exposure context is that the partitioning
of a pollutant into an organism as well as its intra-tissue
diffusion is always directed from high to low chemical activity
and fugacity. Equilibrium partitioning is characterized by
uniform fugacity and chemical activity. This gives very good
possibilities for the study and prediction of internal exposure
and exposure at the target site. Such predictions are limited to
situations where biotransformation is not an issue or
biotransformation rates are known. However, actual measure-
ments of internal chemical activities can then be applied to
support or challenge such predictions and also to establish the
link between internal chemical activities and a toxic response.
Chemical activity is also advantageous for describing
baseline toxicity, which occurs at relatively constant values
ranging between 0.01 and 0.1 (Mayer et al. 2006; Reich-
enberg and Mayer 2006). Chemical activity and fugacity can
be measured with various types of equilibrium sampling
devices (Mayer et al. 2003; Jahnke et al. 2009), such as SPME
fibers (Legind et al. 2007; Ossiander et al. 2008), silicone
microtubings (Mayer et al. 2009), and thinly coated glass slide
or vials (Wilcockson and Gobas 2001; Reichenberg et al.
2008; Golding et al. 2007). The potential of equilibrium
sampling devices for the measurement of internal exposure is
an area of ongoing research.
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ROLE OF BIOTRANSFORMATION
For those organic compounds, such as organophosphates,
DDT, polychlorinated biphenyls, and organotins, that exhibit
specific MoOAs and are metabolized, biotransformation and
metabolite concentrations are an important issue. Biotrans-
formation of chemicals can lead to either detoxification or the
induction (i.e., increased toxicity) of toxic metabolites (e.g.,
benzene transformed to an epoxide by mixed-function
oxygenases [MFO]). Until now, the TRA for metabolized
compounds showing specific toxicity has not been fully
developed, because it is sometimes difficult to obtain a
separate measurement of a parent compound and its
metabolites. This reflects the general lack of ecotoxicological
work that has examined metabolites. However, as shown in
Figure 7, not only may metabolism affect the toxicokinetics,
but the metabolites may also contribute to the toxic effect at
the same or different target site, i.e., through the same or
different mechanisms of toxicity.
Work conducted by Nuutinen et al. (2003) examined the
uptake, biotransformation, and elimination rates of penta-
chlorophenol, methyl parathion, fluoranthene, and hexa-
chlorbiphenyl, as well as their metabolites, in Hyalella
azteca. These investigators found that H. azteca can metab-
olize a variety of chemicals with different modes of action and
that the elimination rates of the metabolites could be
considerably lower than the parent compound and this led
to substantial accumulation of the metabolites. These
investigators argued that if the TRA is to be a ‘‘truly effective
dose metric,’’ it needs to consider the effects caused by
metabolites. By not including the IEC values for metabolites
all current IEC values are either correct (in the case of no
biotransformation) or currently underestimate the true value
(in the case of biotransformation occurring). However, the
extent of the underestimation of the true IEC is currently
unknown and will vary depending on the extent of
biotransformation and the toxicity of the metabolites.
For the TRA to predict toxic effects of metabolizable
chemicals, improvement is needed in 1) predicting whether
chemicals can be biotransformed; 2) determining the
metabolites’ contribution in a mixture of parent chemicals
and metabolites to the observed toxicity; and 3) determining
or predicting the biological half-life of the metabolites
(Fenner et al. 2002; Lienert et al. 2007).
If a chemical can be biotransformed, it means that within
the test organism, even when it is exposed to a single chemical
externally, the toxicity is actually caused by a mixture of the
parent compound and the metabolite(s), provided the
metabolite is toxic. Pioneering work to incorporate this
concept into toxicokinetic and toxicodynamic modeling has
been undertaken in a series of articles by Lee and Landrum
(2006a, 2006b). These investigators reported that the toxic
effects of metabolized polycyclic aromatic hydrocarbon
(PAHs) can be assessed as a ‘‘dynamic’’ mixture of the parent
compound and metabolites with different toxicokinetics and
toxicodynamics (Lee and Landrum 2006a). The toxicoki-
netics and time-dependent toxicity of parent compound and
metabolites for pyrene and fluorene in H. azteca were
separately determined in toxicity and toxicokinetic experi-
ments for parent compound in the presence and absence of a
biotransformation inhibitor. Both metabolites are eliminated
more slowly than the parent compounds; the metabolites of
pyrene are nontoxic, but those of fluorene are toxic.
TOXICOKINETIC MODELING: FROM EXTERNAL
EXPOSURE TO INTERNAL AND TARGET RESIDUES
In most cases, target site concentrations are not exper-
imentally accessible; therefore, we need models to predict
them, which can be done using TK models. Toxicokinetics
can be used to determine the concentration at the target site
by quantifying the processes of uptake and elimination
(passive diffusion, excretion, and metabolism).
The most direct exposure parameter for toxicological
effects is the dose at the target site, or what Paustenbach
(2000) refers to as the biologically effective dose (BED).
Measurement of the dose at the target site is not feasible,
however, necessitating kinetic models with which to predict
the target dose. These toxicokinetic models include processes
such as uptake, biotransformation, internal distribution
between tissues, and excretion (Figure 8). One also has to
consider the distribution of a chemical among several phases
within a tissue, such as the freely dissolved fraction and the
fraction bound to serum proteins, membranes, lipids, cellular
proteins, and receptors. Tissue-specific or organ-specific
residues are one step closer to the dose at the target site,
hence potency differences that are simply related to a
difference in absorption, internal distribution, metabolism,
or excretion can then be ruled out. Two kinds of BED are
considered in ecotoxicology. One is the concentration at the
target site, and the other is receptor occupancy (percentage of
occupied receptors) (Figure 8). The choice of the appropriate
BED depends on the mechanism of toxicity of the toxicant of
interest.
In ecotoxicology, kinetic models are often simple first-
order, 1-compartment models in which the organism is
considered as 1 homogeneous compartment (e.g., Nuutinen
et al. 2003; Ashauer, Caravatti, et al. 2010). In this example,
the whole-body tissue concentration acts as a surrogate for the
concentration at the target site because they are often
proportional. The time course can be described with the
single first-order 1-compartment model in which the uptake
rate is proportional to the toxicant concentration in the
surrounding media and the elimination (depuration) rate is
Figure 7. Extension of Figure 1 for the conditions that metabolites formed
during toxicokinetic phase contribute to toxicity.
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proportional to the toxicant concentration in the organisms,
dCintðtÞ
dt
¼ kin CðtÞkout CintðtÞ; ð3Þ
where Cint is the internal concentration [amountmass1], C
the concentration in the water [amount volume1], and kin
and kout the uptake rate constant [volumemass1 time1]
and the elimination rate constant [time1], respectively
(amount is defined as amount of toxicant, units in mol,
mass refers to the mass of the organism, typically given
as gwet weight).
In this simplified model, the process ‘‘elimination’’ lumps
all processes related to excretion, metabolism, dilution by
growth, and other factors into a single rate constant, resulting
in simple first-order, 1-compartment model where the
organism is considered as 1 homogeneous compartment.
The simple first-order kinetics hold only as long as growth is
zero (slow-growing organisms) or when growth is exponential
over the course of the experiment. Otherwise the model is
more complex (Kooijman et al. 1996). The TK parameters
can be measured in bioconcentration experiments independ-
ent of toxic effect measurements in toxicity tests. Prediction
intervals around internal concentrations and bioaccumulation
factors can also be calculated (Lin et al. 2004; Ashauer,
Caravatti, et al. 2010).
This might be sufficient for small organisms, like daphnids
and copepods, but further refinement is possible (and
necessary) for larger organisms such as fish. Even for the
simple 1-compartment models, however, additional compart-
ments can be included for specific processes such as
metabolism (Nuutinen et al. 2003; Ashauer, Hintermeister,
et al. 2010). Multicompartment models that include storage
lipids and other compartments but that are not physiologi-
cally based are another approach. Modeling and prediction of
dose at the level of a tissue require more sophisticated kinetic
modeling such as physiologically based pharmacokinetic
modeling (PBPK). Physiological parameters such as blood
flow and volume of distribution are incorporated in these
models to make them more realistic. PBPK models designed
for comparison of the toxicological dose of chemicals with a
certain mode of action at the level of a specific tissue, ideally
the target site (Figure 8). PBPK modeling is also a strong tool
in extrapolation among different exposure routes and can
easily handle multiple uptake routes (Andersen et al. 1995;
Yang et al. 1998; Andersen et al. 1999). These models also
allow one to extrapolate back from a tissue or target dose to a
dose in environmental compartments (water, food, soil, and
sediment) in a way similar to that used in food chain models.
The application of PBPK models in ecotoxicology is limited
to kinetic modeling in larger fish such as the rainbow trout
(Nichols et al. 1991, 2004). For example, Nichols et al.
(2004) developed a PBPK model for dietary uptake of
hydrophobic chemicals by fish and applied this same model
to simulate the effects of biotransformation on internal body
residues. Figure 9 presents a simplified scheme of the
compartments and processes of such a PBPK for fish. PBPK
Figure 9. Simplified scheme of a PBPK model for fish. Adapted and reprinted
with permission from Toxicol Sci 77:206–218. Copyright 2004 Oxford
University Press.
Figure 8. Relationship between the different dose metrics and applicability of TK models and PBPK modeling.
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modeling may also be applied to translate and extrapolate
toxicity among different organisms. De Jongh et al. (1998)
analyzed toxicity data for rat from inhalation studies via a
PBPK model and compared the internal effect doses with data
from fish studies. The predicted internal effect concentrations
for nonreactive volatile organic compounds (baseline tox-
icants) were remarkably similar.
TOXICODYNAMIC MODELING
How organisms react as a result of exposure to toxicants is
a crucial component of ecotoxicology. Two alternate views
are used: a deterministic (individual tolerance distribution)
and a stochastic (hazard model) approach. It is important to
understand these alternate views, as both are used by various
TK–TD models and are crucial to ‘‘predicting consequences
to populations after repeated or chronic exposure to any
particular toxicant’’ (Newman and McCloskey, 2000; Zhao
and Newman 2007; Ashauer 2010). The deterministic
approach, or individual tolerance distribution concept,
assumes that each individual has its own unique tolerance
to a toxicant and that when this is exceeded that individual
will exhibit toxic effects (e.g., die). In contrast, the stochastic
approach states that each individual has the same probability
of suffering a toxic effect at a given toxicant concentration.
The apparently subtle differences in these approaches may
lead to different outcomes. Consider a scenario in which a
population was exposed to a sufficiently high concentration of
a toxicant that 50% died and the survivors were then exposed
to no toxicant for sufficient time to permit recovery.
Following this, the survivors were exposed to the same
concentration of toxicant for the same duration. Under the
deterministic approach, there would be no subsequent deaths
because survivors previously tolerated that concentration. In
contrast, under the stochastic approach, 50% of the survivors
from the previous exposure would die, and this would
continue to occur with subsequent exposures. Experiments
by Heagler et al. (1994) and Newman and McCloskey (2000)
revealed that neither approach fully explains the results;
rather, it appeared that the deterministic approach held at
low concentrations whereas the stochastic held at high
exposure concentrations. Recently, a theoretical study dem-
onstrated that a TK–TD modeling approach in which TK–TD
parameters are allowed to vary among individuals in a natural
or experimental population could reproduce key character-
istics of both concepts (Ashauer 2010). This finding suggests
that survival of an individual organism can be characterized
using the hazard model approach (stochastic), and the whole
set of TK–TD parameters for an organism represents
‘‘individual tolerance.’’ The distribution of individual toler-
ances in a population (deterministic approach) is then
represented by the distribution of TK–TD parameters among
individuals (Ashauer 2010).
The deterministic approach predicts that organisms die
immediately once they reach their ILC50. Hence in long-term
experiments those organisms that have reached the ILC50 die
as soon as this internal concentration is reached, whereas the
others that have not reached the ILC50 survive. This
observation is explained traditionally by assuming a distribu-
tion of individual tolerances within that population. Those
individuals that have a tolerance that is lower than the ILC50
will die and those with a higher tolerance will survive, even
after long periods of exposure. Therefore, the population
composition shifts toward more tolerant individuals. An
example is the pulsed Cu exposure to Pimephales promelas
and Daphnia magna observed by Butcher et al. (2006).
However, what exactly the ‘‘individual tolerance’’ represents,
or what dimensions it should have, is not clearly defined.
Furthermore, the shift of the population toward less sensitive
organisms, as well as the phenomenon of ‘‘more sensitive’’
individuals dying and ‘‘less sensitive’’ individuals not dying,
can be explained using a hazard modeling framework in
which TK–TD parameters vary among individuals (Ashauer
2010).
Hazard models assume that death is stochastic. The hazard
rate is the probability of an organism dying at a given point in
time. If, under constant exposure conditions, the hazard rate
is greater than zero, i.e., at least some organisms die, which
means that during constant exposure the hazard rate remains
constant at this value greater than zero, eventually all
organisms will die if the exposure duration is long enough.
One must keep in mind that these are models of limiting cases
and biological reality may often lie somewhere in between.
Toxicodynamic models are generally linked to toxicoki-
netic models and have internal concentrations as a function of
time as input parameters. They describe the dynamics of
injury and recovery in the organism and relate them to the
observed effects. The simplest mathematical description of
toxicodynamics uses a first-order process to describe the
accrual of injury, quantified by the generic measure ‘‘damage’’
(first used by Ankley et al. 1995), and the repair or recovery
of damage (Figure 10). The rate of accrual of damage is
proportional to the rate of accumulation of the toxicant at the
target site and the recovery of damage is proportional to the
amount of damage present, as shown in the following
equation:
dDðtÞ
dt
¼ kk CintðtÞkr DðtÞ ð4Þ
In Eqn. 4, kk is a killing rate constant [mass amount1
time1], kr is the rate constant for damage recovery or repair
[time1] and D(t) is damage [].
One of the underlying assumptions of the TD model
described with Eqn. 4 is that the concentration at the target
site is so low that it does not lead to saturation of the
receptors at the target site. For specific mechanisms of action,
e.g., those for organophosphorus insecticides, the model can
be reformulated to include a limited number of receptors, and
the damage would then be expressed as a fraction of occupied
receptors (Jager et al. 2005).
The processes that affect damage take place at a suborgan-
ism scale. Not all damage necessarily leads to effects that are
observable at the scale of the organism, just as there may be
concentrations of the toxicant in the organism that do not
result in any effect on the organism. Hence this link,
especially for the endpoint survival, often requires a threshold
of effect (Bedaux et al. 1994; Jager et al. 2005; Ashauer et al.
2007a, 2007b; Ashauer and Brown 2008, Ashauer, Hinter-
meister et al. 2010). Threshold values are considered purely
fit parameters, but their mechanistic meaning remains to be
investigated.
Examples of stochastic hazard TK–TD models are the
DEBtox approach (Bedaux et al. 1994; Kooijman et al. 1996;
Pe´ry et al. 2001), more recently the receptor kinetics model
developed by Jager and Kooijman (2005) and the threshold
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damage model (TDM) (all reviewed in Ashauer and Brown
2008). The damage assessment model (DAM) is a determin-
istic toxicity model based on the individual tolerance
distribution (Lee et al. 2002; 2003). The TDM can deal with
fluctuating and pulsed exposure to single and multiple
contaminants (Ashauer et al. 2007a, 2007b; Ashauer et al.
2010b); the DAM has already been applied to model the
mixture effect of internal metabolites formed (Lee and
Landrum 2006a; 2006b).
Relationship between mechanism of action and TK–TD
models
Some TK–TD models can accommodate any speed of
reversibility (DAM, receptor model, and TDM), whereas
others are only applicable to modes of action that show
instantaneous recovery (CBR, DEBtox) or irreversible dam-
age (AUC, CAUC). Table 3 provides an overview of the
discussed models and for which types of toxic mechanisms
they can be applied (see review of Ashauer and Brown 2008).
The model assumptions listed in Table 3 provide a first step
of guidance as to which models are best suited for which
mechanism of action. In general, selecting the appropriate
model is aided by considering 2 kinds of biologically effective
dose for toxicity: 1) tissue residue at target sites, and 2)
receptor occupancy. Information on the mechanism of action
for a toxicant gives a guidance to choose a toxicity model
using tissue residue or receptor occupancy.
In vitro data to support TK–TD modeling
The application of PBPK modeling requires data on tissue–
blood partition coefficients as well as biotransformation rates.
Kinetic parameters, including biotransformation rates from
experiments with isolated cells or microsomes, are often
measured or estimated from in vitro data. However, these
data require a correction for differences in protein binding
between the in vitro and in vivo situation (Houston 1994;
Obach 1997; Riley et al. 2005).
Effect data from in vitro tests may play a role in predicting
in vivo responses through toxicodynamic modeling. One
should also be aware of potential pitfalls in these extrap-
olations. First, in vitro data are often based on nominal
concentrations, and such data are not reliable because actual
concentrations in the in vitro test may be far below the
nominal concentration. Another complicating factor is the
presence of serum proteins that will bind chemicals,
especially the hydrophobic ones. For quantifying toxic effects,
only the unbound fraction of a chemical is relevant. These
phenomena lead to high variability in the outcome of in vitro
tests because the test conditions are not always comparable
(Gu¨lden et al. 1994; Vaes et al. 1996; Gu¨lden et al. 1997;
Nagel et al. 1998; Heringa 2004). As an alternative to total
concentrations, several investigators have proposed using the
concentration of the unbound chemical (Gu¨lden et al. 1994;
Vaes et al. 1996; Heringa 2004), internal cellular, or cell
membrane concentrations (Escher and Schwarzenbach 2002)
as dose parameters because they represent the intrinsic
activity of a chemical. Very recent research suggests that
freely dissolved concentrations or chemical activities in such
in vitro tests can be controlled and maintained constant by
partitioning from a chemically loaded polymer (Bandow et al.
2009; Kwon et al. 2009; Smith et al. 2010). This technique is
expected to facilitate the extrapolation of in vitro data to
environmentally relevant in vivo responses.
Mixture toxicity modeling in toxicokinetic–toxicodynamic
models
How compounds behave in mixtures depends on their
target site and their mode of action (Dyer et al. 2011). If they
Figure 10. Conceptual framework of toxicokinetic–dynamic models.
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act at the same target site and have the same MoOA, they act
together according to the concept of ‘‘concentration addi-
tion’’ (CA). If they have different target sites and do not
interact (also not in the toxicokinetic phase), their toxicity
can be predicted by the mixture toxicity concept of
‘‘independent action’’ (IA) (also termed ‘‘response addition’’)
(Dyer et al. 2011). If there are interactions in the toxico-
kinetic phase or at the target site, synergism and antagonism
may potentially occur. In other words, deviation from the CA
or IA models can be explained by toxicokinetic and/or
toxicodynamic interactions among components in a mixture
(Dyer et al. 2011).
In mixtures, toxicokinetic interactions involve the alter-
ation of metabolism and disposition of 1 compound by
another. These interactions can be mediated by the induction
or inhibition of the activation or detoxification step.
Toxicodynamic interactions include those processes that do
not directly affect the metabolism or disposition of a
xenobiotic but that affect a tissue’s response or susceptibility
to toxic injury. These interactions include depletion or
induction of cytoprotective factors, such as a reduction of
glutathione (Freidig et al. 2001) and alterations in tissue
repair. A very unusual example is the formation of a mixed
heterodimer in protonophoric uncoupling that has a more
potent intrinsic activity than the 2 mixture components
acting independently (Escher et al. 2001).
The contribution of a compound to the mixture toxicity is
expressed in toxic units TUi, defined as the ratio of
concentration of mixture component i to its effect concen-
tration ECp, expressed in either external or internal concen-
tration units, TUi¼Ci/ECpi or TUi¼ ICi/IECpi. Under the
condition of constant exposure conditions, the relationship
between TUs is as follows.
 If critical body residues are time dependent, toxic units
based on body residue as well as those based on external
concentrations are also time dependent.
 In a mixture without toxicological interactions, but with
time-dependent toxicity, there is no difference between the
time-dependent TU concept based on external concen-
trations or body residues (Lee and Landrum 2006b).
 In a mixture with toxic interactions and time-dependent
toxicity where there are toxicokinetic or toxicodynamic
interactions, e.g., competition among different metals
binding to the same ligand or biotransformation inhibition
and/or induction for organic compounds, the TU values
based on body residues are not comparable to TU values
based on external concentrations.
If there are no toxicodynamic interactions within a mixture
then the concept of ‘‘Damage Addition’’ (DA) can be used in
toxicokinetic and toxicodynamic mixture models (Lee and
Landrum 2006b). In this concept the sum of damages from
the individual compounds i yields the total damage for the
mixture:
DmixðtÞ ¼
X
t
DiðtÞ ð5Þ
The DA concept within the DAM can be applied to a
mixture containing compounds with and without toxicoki-
netic interaction. In both cases, the DA model is equivalent to
the CA model (Lee and Landrum 2006b).
Not only are there mixtures of different compounds, but
the formation of metabolites in the body and the resulting
mixture toxicity of parent and metabolite can be looked at as
a mixture effect. Interpreting the metabolites’ contribution to
the observed toxicity is feasible within the body residue
approach and could be improved by better predictions of
biotransformation. The toxic effects of readily metabolized
compounds such as PAHs could be assessed as a mixture of
the parent compound and its metabolites with different
toxicokinetics and toxicodynamics (Lee and Landrum
2006b). Furthermore, the DEBtox survival model was
applied to predict the effects of mixtures of heavy metals in
time (Baas et al. 2007).
Sequential exposure resulting in mixture effects
Exposure of aquatic organisms to contaminants may occur
in repeated sequential pulses (Reinert et al. 2002). Hence
organisms may be exposed to multiple toxicants after each
other. This sequential exposure to multiple compounds
requires a mixture toxicity model that explicitly addresses
the time course of the toxicant concentration in the organism,
i.e., toxicokinetics, as well as the time course of organism
recovery. The TDM provides such a framework and was
recently extended (TDMmix) to address sequential exposure
to multiple compounds (sequential mixtures; Ashauer et al.
2007a). The TDMmix also applies the concept of damage
addition. The sequence of exposure to multiple toxicants was
observed to matter, i.e., that mortality between treatments
differed significantly as a function of order of exposure. This
observation was predicted by the TDMmix model and
explained by the different speed of recovery for the 2
compounds.
Delayed toxicity and time-dependent effect after steady
state
In many cases, lethal body residue is not constant, even
after toxicokinetic steady state is obtained. These observa-
tions can be explained if toxicodynamics are considered as a
second step that has a time dependence, i.e., a kinetic
connotation. When the body residues attain steady state,
critical body residues can be constant (constant CBR model),
or decrease with time (CAUC model, DEBtox model), or
decrease and reach the incipient value (DAM), depending on
the damage recovery rate. The lethal body residue in constant
exposure tests depends on the damage recovery rate as well as
the duration of exposure resulting from the buildup of
damage in the organism with longer-term exposures.
Delayed effects and recovery after exposure are determined
by toxicokinetic and toxicodynamic processes, which control
the velocity of toxicant bioaccumulation, the velocity of the
injury process, and the degree of the reversibility of the toxic
effect (Mancini 1983; Breck 1988; Hickie et al. 1995; Pe´ry
et al. 2001; Pieters et al. 2006). Therefore, the magnitude
and time course of delayed effects depend on factors such
as exposure time, exposure concentration, toxicokinetics,
mode of toxic action, and measurement endpoints, including
lethal or sublethal endpoints such as immobility, growth, and
enzyme activity. Delayed toxicity, i.e., effects after the
exposure period, has been reported, for example, for
herbicides (Cedergreen et al. 2005), Cu (Zhao et al. 2004),
and chlorpyrifos mortality (Van der Hoeven and Gerritsen
1997; Naddy et al. 2000; Naddy and Klaine 2001, Ashauer
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et al. 2007a, 2007c). Addressing delayed effects is particularly
relevant for the risk assessment of intermittent exposure
event or fluctuating concentrations (Reinert et al. 2002;
Ashauer et al. 2006). Application of toxicokinetic and
toxicodynamic models to time-varying exposure conditions
facilitates the understanding of the underlying processes for
delayed toxicity; it also provides a predictive tool. For
example, increased mortality from subsequent pulses of
chlorpyrifos or diazinon to Gammarus pulex, 2 weeks after
the first pulse, could be attributed to toxicodynamic processes
(Ashauer et al. 2007a; Ashauer et al. 2010b). Buildup of
internal concentrations could be excluded, based on previous
measurements of internal concentrations and toxicokinetic
simulation.
RECOMMENDATIONS FOR FUTURE RESEARCH
Target site concentration or critical reaction rates with the
target are useful measures to unify the description of toxicity
between different species, chemicals, and exposure regimes.
As this review has demonstrated, even for the ‘‘simple’’
mechanism of baseline toxicity, whole-body tissue residues
are not necessarily sufficient surrogates of the target site
concentration. In practice, it is difficult and in many cases
impossible to determine target site concentrations experi-
mentally; therefore, we should continue to focus on measur-
ing whole-body tissue residues for small organisms and target
organ tissue residues for larger animals but try to complement
the measurements by additional information like lipid content
and protein content determination to facilitate modeling of
target site concentrations. The present work reviews the latest
advances in equilibrium partitioning for simpler experimental
approximation of tissue residues.
In addition, we advocate the use of TK/TD modeling as a
tool to refine the tissue residue approach. Variability in the
toxicity of different toxicants is due to the toxicant character-
istics. Some physicochemical characteristics affect the tox-
icokinetics, whereas others modify the toxicodynamics. In
contrast, the variability in species sensitivity to toxicants
could be attributed to species-specific traits. Some trait
differences may be important for toxicokinetics, whereas
others may be relevant for toxicodynamics. Hence, explicit
process understanding and modeling of toxicokinetics and
toxicodynamics may facilitate a more complete understanding
of the variability inherent in ecotoxicological data and
processes.
Specific recommendations for further research include the
following:
 Further testing and validation of equilibrium sampling
devices and diffusive sampler techniques to measure or
estimate internal dose as well as chemical activity as a more
unifying dose metric
 Exploring alternative empirical parameters as a measure for
the effects of specific acting chemicals
 Refinement of the body residue concept by measuring
tissue-based residues and the application of kinetic model-
ing in analyzing these tissue-based residues
 Including alternative measured descriptors such as critical
depletion rates in TK–TD models
 Seeking further insight into the role of metabolism on
body, or tissue, residue-based interpretation of toxicolog-
ical effects
Acknowledgment—The authors thank the numerous spon-
sors for their generous financial contributions that supported
this workshop. We thank Thomas Preuss and Tjalling Jager for
helpful discussions; Theo Traas and Jan Hendriks for providing
data compilations published in (Hendriks et al. 2005); and
Lynn McCarty, Nancy Beckvar, Peter Landrum, Stuart
Simpson, Jenny Stauber, and Jan Hendriks for helpful com-
ments on the manuscript. The opinions and views expressed in
this paper are those of the authors and do not necessarily reflect
views and policies of their affiliated institutions.
REFERENCES
Abernethy SG, Mackay D, McCarty LS. 1988. ‘‘Volume fraction’’ correlation for
narcosis in aquatic organisms: The key role of partitioning. Environ Toxicol
Chem 7:469–481.
Alda Alvarez O, Jager T, Redondo EM, Kammenga JE. 2006. Physiological modes of
action of toxic chemicals in the nematode Acrobeloides nanus. Environ Toxicol
Chem 25:3230–3237.
Amdur M, Doull J, Klaassen C, editors. 1991. Cassarett and Doull’s toxicology. The
basic science of poisons 4th ed. New York (NY): Pergamon. 1033 p.
Andersen ME, Clewell H Jr, Frederick CB. 1995. Applying simulation modelling to
problems in toxicology and risk assessment—a short perspective. Toxicol Appl
Pharmacol 133:181–187.
Andersen ME, Conolly RB, Fausman KEM, Ziese L. 1999. Quantitative
mechanistically based dose-response modeling with endocrine-active
compounds. Environ Health Persp 107 (Suppl 4): 631–638.
Ankley GT, Erickson RJ, Phipps GL, Mattson VR, Kosian PA, Sheedy BR, Cox JS. 1995.
Effects of light-intensity on the phototoxicity of fluoranthene to a benthic
macroinvertebrate. Environ Sci Technol 29:2828–2833.
Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR,
Nichols JW, Russom CL, Schmieder PK, Serrrano JA, Tietge JE, Villeneuve DL.
2010. Adverse outcome pathways: A conceptual framework to support
ecotoxicology research and risk assessment. Environ Toxicol Chem 29:730–741.
Antkowiak B. 2001. How do general anaesthetics work? Naturwissenschaften
88:201–213.
Ashauer R. 2010. Toxicokinetic–toxicodynamic modelling in an individual based
context—consequences of parameter variability. Ecol Modell 221:1325–1328.
Ashauer R, Brown CD. 2008. Toxicodynamics assumptions in ecotoxicological
models. Environ Chem Toxicol 27:1817–1821.
Ashauer R, Boxall ABA, Brown CD. 2006. Predicting effects on aquatic organisms
from fluctuating or pulsed exposure to pesticides. Environ Toxicol Chem
25:1899–1912.
Ashauer R, Boxall ABA, Brown CD. 2007a. New ecotoxicological model to simulate
survival of aquatic invertebrates after exposure to fluctuating and sequential
pulses of pesticides. Environ Sci Technol 41:1480–1486.
Ashauer R, Boxall ABA, Brown CD. 2007b. Simulating toxicity of carbaryl to
Gammarus pulex after sequential pulsed exposure. Environ Sci Technol
41:5528–5534.
Ashauer R, Caravatti I, Hintermeister A, Escher BI. 2010a. Bioaccumulation kinetics
of organic xenobiotic pollutants in the freshwater invertebrate Gammarus
pulexmodelled with prediction intervals. Environ Toxicol Chem 29:1625–1636.
Ashauer R, Hintermeister A, Caravatti I, Kretschmann A, Escher BI. 2010b. Carry-
over toxicity from exposure to diazinon is explained by toxicokinetic–
toxicodynamic modeling of biotransformation and slow organism recovery.
Environ Sci Technol 44:3963–3971.
Baas J, Van Houte BPP, Van Gestel CAM, Kooijman SALM. 2007. Modelling the
effects of binary mixtures on survival in time. Environ Toxicol Chem 26:1320–
1327.
Bandow N, Altenburger R, Lu¨bcke-von Varel U, Paschke A, Streck G, Brack W. 2009.
Partitioning-based dosing: An approach to include bioavailability in the effect-
directed analysis of contaminated samples. Environ Sci Technol 43:3891–3896.
Barron MG, Hansen J, Lipton J. 2002. Association between contaminant tissue
residues and effects in aquatic animals. Rev Environ Contam Toxicol 173:1–37.
Bedaux JJM, Kooijman SALM. 1994. Statistical analysis of bioassays based on
hazard modelling. Environ Ecol Stat 1:303–314.
46 Integr Environ Assess Manag 7, 2011—BI Escher et al.
Bradbury SP. 1994. Predicting modes of toxic action from chemical structure. An
overview. SAR QSAR Environ Res 2:89–104.
Breck JE. 1988. Relationships among models for acute toxicity effects: Application
to fluctuating concentrations. Environ Toxicol Chem 7:775–778.
Butcher J, Diamon J, Bearr J, Latimer H, Klaine S, Hoang T, Bowersox M. 2006.
Toxicity models of pulsed copper exposure to Pimephales promelas and
Daphnia magna. Environ Toxicol Chem 25:2541–2550.
Cedergreen N, Andersen L, Olesen CF, Spliid HH, Streibig JC. 2005. Does the effect
of herbicide pulse exposure on aquatic plants depend on Kow or mode of
action? Aquat Toxicol 71:261–271.
Chaisuksant Y, Yu QM, Connell D. 1997. Internal lethal concentrations
of halobenzenes with fish (Gambusia affinis). Ecotoxicol Environ Saf
37:66–75.
Chaisuksant Y, Yu QM, Connell DW. 1999. The internal critical level concept of
nonspecific toxicity. Rev Environ Contam Toxicol 162:1–41.
Collins F, Gray GN, Bucher JR. 2008. Transforming environmental health protection.
Science 319:906–907.
De Bruyn A, Gobas F. 2007. The sorptive capacity of animal protein. Environ Toxicol
Chem 26:1803–1808.
de Jongh J, Verhaar HJM, Hermens JLM. 1998. Role of kinetics in acute lethality of
nonreactive volatile organic compounds (VOCs). Toxicol Sci 45:26–32.
Deneer JW, Seinen W, Hermens JLM. 1988. The acute toxicity of aldehydes to the
guppy. Aquat Toxicol 12:185–192.
Deneer JW, Sinnige TL, Seinen W, Hermens JLM. 1988. A quantitative structure–
activity relationship for the acute toxicity of some epoxy compounds to the
guppy. Aquat Toxicol 13:195–204.
Drummond RA, Russom CL. 1990. Behavioral toxicity syndromes—a promising tool
for assessing toxicity mechanisms in juvenile fathead minnows. Environ Toxicol
Chem 9:37–46.
Dyer S, Warne MSJ, Meyer JS, Leslie HA, Escher BI. 2011. The tissue residue
approach for chemical mixtures. Integr Environ Assess Manag 7:99–115.
Escher BI, Hermens JLM. 2002. Modes of action in ecotoxicology: Their role in body
burdens, species sensitivity, QSARs, and mixture effects. Environ Sci Technol
36:4201–4217.
Escher B, Schwarzenbach RP. 2002. Mechanistic studies on baseline toxicity and
uncoupling as a basis for modeling internal lethal concentrations in aquatic
organisms. Aquat Sci 64:20–35.
Escher BI, Hermens JLM. 2004. Internal exposure—linking bioavailability to effects.
Environ Sci Technol 38:455A–462A.
Escher BI, Hunziker R, Westall JC, Schwarzenbach RP. 1999. Kinetic model to
describe the intrinsic uncoupling activity of substituted phenols in energy
transducing membranes. Environ Sci Technol 33:560–570.
Escher BI, Hunziker RW, Schwarzenbach RP. 2001. Interaction of phenolic
uncouplers in binary mixtures: Concentration-additive and synergistic
effects. Environ Sci Technol 35:3905–3914.
Escher BI, Eggen RIL, Schreiber U, Schreiber Z, Vye E, Wisner B, Schwarzenbach RP.
2002. Baseline toxicity (narcosis) of organic chemicals determined by
membrane potential measurements in energy-transducing membranes.
Environ Sci Technol 36:1971–1979.
Fenner K, Kooijman C, Scheringer M, Hungerbuhler K. 2002. Including
transformation products into the risk assessment for chemicals: The case of
nonylphenol ethoxylate usage in Switzerland. Environ Sci Technol 36:1147–
1154.
Ferguson J. 1939. The use of chemical potentials as indices of toxicity. Proc R Soc
Lond Ser B Biol Sci 127:387–404.
Franks NP, Lieb WR. 1990. Mechanisms of general anaesthesia. Environ Health
Persp 87:199–205.
Franks NP, Lieb WR. 1994. Molecular and cellular mechanisms of general
anaesthesia. Nature 367:607–614.
Freidig AP, Hermens JLM. 2001. Narcosis and chemical reactivity QSARs for acute
fish toxicity. Quant Struct Activity Relat 19:547–553.
Freidig AP, Verhaar HJM, Hermens JLM. 1999. Comparing the potency of chemicals
with multiple modes of action in aquatic toxicology: Acute toxicity due to
narcosis versus reactive toxicity of acrylic compounds. Environ Sci Technol
33:3038–3043.
Freidig AP, Hofhuis M, Van Holstijn I, Hermens JLM. 2001. Glutathione depletion in
rat hepatocytes: A mixture toxicity study with a,b-unsaturated esters.
Xenobiotica 31:295–307.
Gerritsen A, van der Hoeven N, Pielaat A. 1998. The acute toxicity of selected
alkylphenols to young and adult Daphnia magna. Ecotoxicol Environ Saf
39:227–232.
Golding CJ, Gobas F, Birch GF. 2007. Characterization of polycyclic aromatic
hydrocarbon bioavailability in estuarine sediments using thin-film extraction.
Environ Toxicol Chem 26:829–836.
Gu¨lden M, Seibert H. 1997. Influence of protein binding and lipophilicity on the
distribution of chemical compounds in in-vitro systems. Toxicol In Vitro 11:479–
483.
Gu¨lden M, Seibert H, Voss JU. 1994. Inclusion of physicochemical data in
quantitative comparisons of in-vitro and in-vivo toxic potencies. ATLA-Altern
Lab Anim 22:185–192.
Harder A, Escher BI, Schwarzenbach RP. 2003. Applicability and limitations of
QSARs for the toxicity of electrophilic chemicals. Environ Sci Technol 37:4955–
4961.
Harder A, Escher BI, Landini P, Tobler NB, Schwarzenbach RP. 2003. Evaluation of
bioanalytical tools for toxicity assessment and mode of toxic action
classification of reactive chemicals. Environ Sci Technol 37:4962–4970.
Heagler M, Newman M, Mulvey M, Dixon P. 1994. Allozyme genotype in
mosquitofish, Gambusia holbroki, during mercury exposure: Temporal
stability, concentration effects and field verification. Environ Toxicol Chem
12:385–395.
Hendriks AJ, Traas TP, Huijbregts MAJ. 2005. Critical body residues linked to
octanol–water partitioning, organism composition, and LC50 QSARs: Meta-
analysis and model. Environ Sci Technol 39:3226–3236.
Heringa MB. 2004. In: Institute for Risk Assessment Sciences. Utrecht (NL): Utrecht
Univ.
Heringa MB, Hermens JL. 2003. Measurement of free concentration using
negligible-depletion-solid phase microextraction (nd-SPME). Trends Anal
Chem 22:575–587.
Heringa MB, Schreurs R, Busser F, Van Der Saag PT, Van Der Burg B, Hermens JLM.
2004. Toward more useful in vitro toxicity data with measured free
concentrations. Environ Sci Technol 38:6263–6270.
Hermens J, Leeuwangh P. 1982. Joint toxicity of mixtures of 8 and 24 chemicals to
the guppy (Poecilia reticulata). Ecotoxicol Environ Saf 6:302–310.
Heugens EHW, Jager T, Creyghton R, Kraak MHS, Hendriks AJ, Van Straalen NM,
Admiraal W. 2003. Temperature-dependent effects of cadmium on
Daphnia magna: Accumulation versus sensitivity. Environ Sci Technol
37:2145–2151.
Hickie BE, McCarty LS, Dixon DG. 1995. A residue-based toxicokinetic model for
pulse-exposure toxicity in aquatic systems. Environ Toxicol Chem 14:2187–
2197.
Houston JB. 1994. Utility of in vitro drug metabolism data in predicting in vivo
metabolic clearance. Biochem Pharmacol 47:1469–1479.
Huckins JN, Tubergen MW, Manuweera GK. 1990. Semipermeable membrane
devices containing model lipids—a new approach to monitoring the
bioavailability of lipophilic contaminants and estimating their
bioaccumulation potential. Chemosphere 20:533–552.
Hunziker RW, Escher BI, Schwarzenbach RP. 2001. PH-dependence of partitioning
of triphenyltin and tributyltin between phosphatidylcholine liposomes and
water. Environ Sci Technol 35:3899–3904.
Hunziker RW, Escher BI, Schwarzenbach RP. 2002. Acute toxicity of organotin
compounds: Different specific effects on the energymetabolism and role of pH.
Environ Toxicol Chem 21:1191–1197.
Jager T, Kooijman S. 2005. Modeling receptor kinetics in the analysis of survival data
for organophosphorus pesticides. Environ Sci Technol 39:8307–8314.
Jahnke A, Mayer P, Broman D, McLachlan M. 2009. Equilibrium sampling using
polydimethylsiloxane in fish tissue—possibilities and limitations. Chemosphere
77:764–770.
Kishino T, Kobayashi K. 1995. Relation between toxicity and accumulation of
chlorophenols at various pH, and their absorption mechanism in fish. Water
Res 29:431–442.
Mode of Action and Tissue Residues—Integr Environ Assess Manag 7, 2011 47
Ko¨nemann H. 1981. Quantitative structure–activity relationships in fish toxicity
studies. Part 1. Rrelationship for 50 industrial pollutants. Toxicology 19:209–
221.
Kooijman SALM. 2000. Dynamic energy and mass budgets in biological systems.
New York (NY): Cambridge Univ. 424 p.
Kooijman SALM, Bedaux JJM. 1996. Analysis of toxicity tests on Daphnia survival
and reproduction. Water Res 30:1711–1723.
Krasowski M, Harrison N. 1999. General anesthetic actions on ligand-gated ion
channels. Cell Mol Life Sci 55:1278–1303.
Kwon J-H, Wu¨thrich T, Mayer P, Escher BI. 2009. Development of a dynamic delivery
method for in vitro bioassays. Chemosphere 76:83–90.
Lee JH, Landrum PF. 2006a. Application of multi-component damage assessment
model (MDAM) for the toxicity of metabolized PAH in Hyalella azteca. Environ
Sci Technol 40:1350–1357.
Lee JH, Landrum PF. 2006b. Development of a multi-component damage
assessment model (MDAM) for time-dependent mixture toxicity with
toxicokinetic interactions. Environ Sci Technol 40:1341–1349.
Lee JH, Landrum PF, Koh CH. 2002. Prediction of time-dependent PAH toxicity in
Hyalella azteca using a damage assessment model. Environ Sci Technol
36:3131–3138.
Lee JH, Landrum PF, Koh CH. 2003. Toxicokinetics and time-dependent PAH
toxicity in the amphipod Hyalella azteca. Environ Sci Technol 36:3124–
3130.
Legierse KCHM, Verhaar HJM, Vaes WHJ, De Bruijn JHM, Hermens JLM. 1999.
Analysis of the time-dependent acute aquatic toxicity of organophosphorus
pesticides: The critical target occupation model. Environ Sci Technol 33:917–
925.
Legind C, Karlson U, Burken J, Reichenberg F, Mayer P. 2007. Determining chemical
activity of (semi)volatile compounds by headspace solid phase microextraction.
Anal Chem 79:2869–2876.
Leslie HA, Oosthoek AJP, Busser FJM, Kraak MHS, Hermens JLM. 2002. Biomimetic
solid-phase microextraction to predict body residues and toxicity of chemicals
that act by narcosis. Environ Toxicol Chem 21:229–234.
Leslie HA, Kraak MHS, Hermens JLM. 2004. Chronic toxicity and body residues of
the nonpolar narcotic 1,2,3,4-tetrachlorobenzene in Chironomus riparius.
Environ Toxicol Chem 23:2022–2028.
Lienert J, Gu¨del K, Escher BI. 2007. Screening method for ecotoxicological hazard
assessment of 42 pharmaceuticals considering human metabolism and
excretory routes. Environ Sci Technol 41:4471–4478.
Lin HI, Berzins DW, Myers L, George WT, Abdelghani A, Watanabe KH. 2004. A
Bayesian approach to parameter estimation for a crayfish (Procambarus spp)
bioaccumulation model. Environ Toxicol Chem 23:2259–2266.
Lipnick RL. 1989. Hans Horst Meyer and the lipoid theory of narcosis. TiPS 10:265–
269.
Lipnick RL, Watson K, Strausz A. 1987. A QSAR study of the acute toxicity of
some industrial organic chemicals to goldfish. Narcosis, electrophile and
proelectrophile mechanism. Xenobiotica 17:1011–1025.
Mackay D. 2004. Finding fugacity feasible, fruitful and fun. Environ Toxicol Chem
23:2282–2289.
Mackay D, Arnot J, Petkova E, Wallace K, Call D, Brooke L, Veith G. 2009. The
physicochemical basis of QSARs for baseline toxicity. SAR QSAR Environ Res
20:393–394.
Mancini JL. 1983. A method for calculating effects, on aquatic organisms, of time
varying concentrations. Water Res 17:1355–1362.
Mayer P, Reichenberg F. 2006. Can highly hydrophobic organic substances cause
aquatic baseline toxicity and can they contribute to mixture toxicity? Environ
Toxicol Chem 25:2639–2644.
Mayer P, Tolls J, Hermens L, Mackay D. 2003. Equilibrium sampling devices. Environ
Sci Technol 37:184A–191A.
Mayer P, Tora¨ng L, Glæsner N, Jo¨nnson J. 2009. Silicone membrane equilibrator—
measuring chemical activity of non-polar chemicals with PDMS micro-tubes
immersed directly within tissue and lipids. Anal Chem 81:1536–1542.
McCarty LS, Mackay D. 1993. Enhancing ecotoxicological modeling and
assessment: Body residues and modes of toxic action. Environ Sci Technol
27:1719–1728.
McCarty LS, Mackay D, Smith AD, Ozburn AD, Dixon DG. 1993. Residue-based
interpretation of toxicity and bioconcentration QSARs from aquatic bioassays:
Polar narcotic organics. Ecotoxicol Environ Saf 25:253–270.
McCarty LS, Landrum PF, Luoma SN, Meador JP, Merten AA, Shephard BK, von
Wezel AP. 2011. Advancing environmental toxicology through chemical
dosimetry: external exposures versus tissue residues. Integr Environ Assess
Manag 7:7–27.
McKim JM, Schmieder P. 1991. Bioaccumulation: Does it reflect toxicity?. In: Nagel
R, Loskill R, editors. Bioaccumulation in aquatic systems: Contributions to the
assessment. Weinheim, Germany: VCH Verlagsgesellschaft, p 161–188.
McKim JM, Bradbury SP, Niemi GJ. 1987a. Fish acute toxicity syndromes and their
use in the QSAR approach to hazard assessment. Environ Health Persp 71:171–
186.
McKim JM, Schmieder PK, Carlson RW, Hunt EP, Niemi GJ. 1987b. Use of
respiratory-cardiovascular responses of rainbow-trout (Salmo gairdneri) in
identifying acute toxicity syndromes in fish.1. Pentachlorophenol, 2,4-
dinitrophenol, tricaine methanesulfonate and 1-octanol. Environ Toxicol
Chem 6:295–312.
Meador JP. 2006. Rationale and procedures for using the tissue-residue approach
for toxicity assessment and determination of tissue, water, and sediment quality
guidelines for aquatic organisms. Hum Ecol Risk Assess 12:1018–1073.
Meador JP, McCarty L, Escher B, Adams W. 2008. The tissue-residue approach for
toxicity assessment: Concepts, issues, application, and recommendations. J
Environ Monitor 10:1486–1498.
Meyer HH. 1899. Zur Theorie der Alkoholnarkose. I. Welche Eigenschaft der
Anesthetica bedingt ihre narkotische Wirkung. Arch Exp Pathol Pharmakol
42:109–118.
Moody E, Skolnick P. editors 2001. Molecular basis of anesthesia. Boca Raton (FL):
CRC. 330 p.
Naddy RB, Klaine SJ. 2001. Effect of pulse frequency and interval on the toxicity of
chlorpyrifos to Daphnia magna. Chemosphere 45:497–506.
Naddy RB, Johnson KA, Klaine SJ. 2000. Response of Daphnia magna to pulsed
exposures of chlorpyrifos. Environ Toxicol Chem 19:423–431.
Nagel SC, vom Saal FS, Welshons WV. 1998. The effective free fraction of estradiol
and xenoestrogens in human serum measured by whole cell uptake assays:
Physiology of delivery modifies estrogenic activity. Proc Soc Exp Biol Med
217:300–309.
National Toxicology Program. 2004. A national toxicology program for the 21st
century: A roadmap for the future. National Institute of Environmental Health
Sciences (NIEHS). Available from: http://ntp.niehs.nih.gov/go/vision
Nendza M, Wenzel A. 2006. Discriminating toxicant classes by mode of action. 1.
(Eco)toxicity profiles. Environ Sci Pollut Res 13:192–203.
Nendza M, Wenzel A, Wienen G. 1995. Classification of contaminants by mode of
action based on in vitro assays. SAR QSAR Environ Res 4:39–50.
Neuwoehner J, Junghans M, Koller M, Escher BI. 2008. QSAR analysis and specific
endpoints for classifying the physiological modes of action of biocides in
synchronous green algae. Aquat Toxicol 90:8–18.
Neuwoehner J, Fenner K, Escher BI. 2009. Physiological modes of action of fluoxetine
and its human metabolites in algae. Environ Sci Technol 43:6830–6837.
Newman M, McCloskey J. 2000. The individual tolerance concept is not the sole
explanation for the probit dose-effect model. Environ Toxicol Chem 19:520–
526.
Nichols JW, McKim JM, Lien GJ, Hoffman AD, Bertelsen SL. 1991. Physiologically
based toxicokinetic modeling of three waterborne chloroethanes in rainbow
trout (Oncorhynchus mykiss). Toxicol Appl Pharmacol 110:374–389.
Nichols JW, Fitzsimmons PN, Whiteman FW, Dawson TD, Babeu L, Juenemann J.
2004. A physiologically based toxicokinetic model for dietary uptake of
hydrophobic organic compounds by fish. I. Feeding studies with 2,20,5,50-
tetrachlorobiphenyl. Toxicol Sci 77:206–218.
Nishikawa J-I, Mamiya S, Kanayama T. 2004. Involvement of the retinoidreceptor
in the development of imposex caused by organotins in gastropods. Environ Sci
Technol 38:6271–6276.
Nuutinen S, Landrum P, Schuler L, Kukkonen J, Lydy M. 2003. Toxicokinetics of
organic contaminants in Hyalella azteca. Arch Environ Contam Toxicol 44:467–
475.
48 Integr Environ Assess Manag 7, 2011—BI Escher et al.
Obach RS. 1997. Nonspecific binding tomicrosomes: Impact on scale-up on in vitro
intrinsic clearance to hepatic clearance as assessed through examination of
warfarin, imipramine and propanolol. Drug Metab Disp 25:1359–1369.
Oravcova J, Bohs B, Lindner W. 1996. Drug–protein binding studies. New trends in
analytical and experimental methodology. J Chromatogr B 677:1–28.
Ossiander L, Reichenberg F, McLachlan M, Mayer P. 2008. Immersed solid phase
micro extraction to measure chemical activity of lipophilic organics in fatty
tissue samples. Chemosphere 71:1502–1510.
Overton E. 1899. U¨ber die allgemeinen osmotischen Eigenschaften der Zelle, ihre
vermutlichen Ursachen und ihre Bedeutung fu¨r die Physiologie.
Vierteljahreszeitschrift der Naturforschenden Gesellschaft in Zu¨rich 44:88–135.
Paustenbach DJ. 2000. The practice of exposure assessment: A state-of-the-art
review. J Toxicol Environ Health B Crit Rev 3:179–291.
Pe´ry ARR, Bedaux JJM, Zonneveld C, Kooijman SALM. 2001. Analysis of bioassays
with time-varying concentrations. Water Res 35:3825–3832.
Pieters BJ, Jager T, Kraak MHS, Admiraal W. 2006. Modeling responses of Daphnia
magna to pesticide pulse exposure under varying food conditions: Intrinsic
versus apparent sensitivity. Ecotoxicology 15:601–608.
Rand G, Wells P, McCarty LS. 1995. Introduction to aquatic toxicology. In: R G,
editors. Fundamentals of aquatic toxicology 2nd ed. Washington (DC): Taylor &
Francis, p 3–67.
Reichenberg F, Mayer P. 2006. Two complementary sides of bioavailability:
Accessibility and chemical activity of organic contaminants in sediments and
soils. Environ Toxicol Chem 25:1239–1245.
Reichenberg F, Smedes F, Jonsson JA, Mayer P. 2008. Determining the chemical
activity of hydrophobic organic compounds in soil using polymer coated vials.
Chem Central J 2:8.
Reinert KH, Giddings JM, Judd L. 2002. Effects analysis of time-varying or repeated
exposures in aquatic ecological trisk assessment of agrochemicals. Environ
Toxicol Chem 21:1977–1992.
Riley RJ, McGinnity DF, Austin RP. 2005. A unified model for predicting human
hepatic, metabolic clearance from in vitro intrinsic clearance data in
hepatocytes and microsomes. Drug Metab Dispos 33:1304–1311.
Roberts DW, Costello JF. 2003. Mechanisms of action for general and polar narcosis:
A difference in dimension. QSAR Combin Sci 22:226–233.
Sandermann H. 1993. Induction of lipid–protein mismatch by xenobiotics with
general membrane targets. Biochim Biophys Acta 1150:130–133.
Schwarzenbach RP, Gschwend PM, Imboden DM. 2003. Environmental organic
chemistry 2nd ed. New York (NY): Wiley. 1313 p.
Seeman P, Roth S, Schneider H. 1971. The membrane concentration of alcohol
anaesthetics. Biochim Biophys Acta 225:171–184.
Sijm DTHM, Hermens JLM. 2000. Internal effect concentrations: Link
between bioaccumulation and ecotoxicity for organic chemicals. In: Beek B,
editor. The handbook of environmental chemistry Vol 2J. Berlin (DE): Springer, p
167–199.
Smith KEC, Oostingh GJ, Mayer P. 2010. Passive dosing for producing defined and
constant exposure of hydrophobic organic compounds during in vitro toxicity
tests. Chem Res Toxicol 23:55–65.
Spycher S, Escher BI, Gasteiger J. 2005. A QSAR model for the intrinsic activity of
uncouplers of oxidative phosphorylation. Chem Res Toxicol 18:1858–1867.
Spycher S, Smejtek P, Netzeva TI, Escher BI. 2008. Towards a class-independent
quantitative structure–activity relationship model for uncouplers of oxidative
phosphorylation. Chem Res Toxicol 21:911–927.
Terada H. 1990. Uncouplers of oxidative phosphorylation. Environ Health Persp
87:213–218.
Timbrell J. 2000. Principles of biochemical toxicology. Washington (DC): Taylor &
Francis. 394 p.
Traas TP, van Wezel AP, Hermens JLM, Zorn M, van Hattum AGM, Van Leeuwen CJ.
2004. Environmental quality criteria for organic chemicals predicted from
internal effect concentrations and a food web model. Environ Toxicol Chem
23:2518–2527.
Urrestarazu Ramos E, Vaes WHJ, Verhaar HJM, Hermens JLM. 1998. A proposed
mechanism for narcosis mode of action. In: Urrestarazu Ramos E, editor.
Aquatic toxicity of polar narcotic pollutants. Dissertation. RITOX. Utrecht
(NL) Utrecht Univ. p 120–129.
Vaes WHJ, Urrestarazu-Ramos E, Verhaar HJM, Seinen W, Hermens JLM. 1996.
Measurement of the free concentration using solid-phase microextraction:
Binding to protein. Anal Chem 68:4463–4467.
Vaes WHJ, Urrestarazu-Ramos E, Hamwick C, van Holstein I, Blaauboer BJ, Seinen
W, Verhaar HJM, Hermens JLM. 1997. Solid phase microextraction as a tool to
determine membrane/water partition coefficients and bioavailable
concentrations in in-vitro systems. Chem Res Toxicol 10:1067–1072.
Vaes WHM, Urrestarazu-Ramos E, Verhaar H, Hermens JLM. 1998. Acute toxicity of
nonpolar versus polar narcosis: Is there a difference? Environ Toxicol Chem
17:1380–1384.
Vallotton N, Eggen RIL, Escher BI, Krayenbuhl J, Che`vre N. 2008. Effect of pulse
herbicidal exposure on Scenedesmus vacuolatus: A comparison of two
photosystem II inhibitors. Environ Toxicol Chem 27:1399–1407.
Van der Hoeven N, Gerritsen AAM. 1997. Effects of chlorpyrifos on individuals and
populations of Daphnia pulex in the laboratory and field. Environ Toxicol Chem
16:2438–2447.
van Hoogen G, Opperhuizen A. 1988. Toxicokinetics of chlorobenzenes in fish.
Environ Tox Chem 7:213–219.
van Wezel AP, de Vries DAM, Kostense S, Sijm DTHM, Opperhuizen A. 1995.
Intraspecies variation in lethal body burdens of narcotic compounds. Aquat
Toxicol 33:325–342.
van Wezel AP, Opperhuizen A. 1995. Narcosis due to environmental pollutants in
aquatic organisms: Residue-based toxicity, mechanisms, and membrane
burdens. Crit Rev Toxicol 25:255–279.
Veith GD, Broderius SJ. 1990. Rules for distinguishing toxicants that cause type I
and type II narcosis syndromes. Environ Health Persp 87:207–211.
Veith GD, Call DJ, Brooke LT. 1983. Structure–toxicity relationships for the fathead
minnow, Pimephales promelas: Narcotic industrial chemicals. Can J Fish Aquat
Sci 40:743–748.
Verhaar HJM, van Leeuwen CJ, Hermens JLM. 1992. Classifying environmental
pollutants. 1. Structure–activity relationships for prediction of aquatic toxicity.
Chemosphere 25:471–491.
Verhaar HJM, Busser FJM, Hermens JLM. 1995. A surrogate parameter for baseline
toxicity content of contaminant water: Simulating bioconcentration and
counting molecules. Environ Sci Technol 29:726–734.
Verhaar HJM, Urrestarazu-Ramos E, Hermens JLM. 1996. Classifying environmental
pollutants. 2. Separation of class 1 (baseline toxicity) and class 2 (‘‘polar
narcosis’’) type compounds based on chemical descriptors. J Chemometrics
10:149–162.
Verhaar HJM, De Wolf W, Dyer S, Legierse KCHM, Seinen W, Hermens JLM. 1999.
An LC50 vs time model for the aquatic toxicity of reactive and receptor-
mediated compounds. Consequences for bioconcentration kinetics and risk
assessment. Environ Sci Technol 33:758–763.
Warne MSJ, Hawker DW. 1995. The number of components in a mixture
determines whether synergistic and antagonistic or additive toxicity
predominate—the funnel hypothesis. Ecotoxicol Environ Saf 31:23–28.
Warne MSJ, Connell DW, Hawker DW. 1991. Comparison of the critical
concentration and critical volume hypotheses of non-specific toxicity for
individual compounds. Toxicology 66:187–195.
Wilcockson JB, Gobas FAPC. 2001. Thin-film solid-phase extraction to measure
fugacities of organic chemicals with low volatility in biological samples. Environ
Sci Technol 35:1425–1431.
Yang RSH, Thomas RS, Gustafson DL, Campain J, Benjamin SA, Verhaar HJM,
Mumtaz MM. 1998. Approaches to developing alternative and predictive
toxicology based on PBPK/PD and QSAR modeling. Environ Health Persp
6:1385–1393.
Yu QM, Chaisuksant Y, Connell D. 1999. A model for non-specific toxicity with
aquatic organisms over relatively long periods of exposure time. Chemosphere
38:909–918.
Zhao Y, Newman MC. 2004. Shortcomings of the laboratory-derived median lethal
concentration for predicting mortality in field populations: Exposure duration
and latent mortality. Environ Chem Toxicol 23:2147–2153.
Zhao Y, Newman MC. 2007. The theory underlying dose-response models
influences predictions for intermittent exposures. Environ Toxicol Chem 26:
543–547.
Mode of Action and Tissue Residues—Integr Environ Assess Manag 7, 2011 49
